data_5ug3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ug3 _Structure_validation_residue.Date_analyzed 2017-09-01 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.936 0.398 . . . . 3.8199999999999998 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 2.9399999999999999 110.465 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -70.49 -9.01 55.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.693 -0.685 . . . . 1.29 111.798 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 t -64.65 -31.61 72.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.769 0.318 . . . . 1.3300000000000001 110.509 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 t -87.0 20.54 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.601 0.715 . . . . 1.8 109.67 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 30.0 m-80 -132.47 111.36 13.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.178 -0.919 . . . . 0.42999999999999999 109.492 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.43 -13.65 40.91 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.143 1.896 . . . . 1.1499999999999999 112.487 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 13' ' ' VAL . 23.8 t -84.23 -31.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 1.9099999999999999 110.315 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 85.5 m -76.33 -50.28 14.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.652 -0.419 . . . . 1.29 110.243 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 19.9 ptt180 -71.15 -17.01 62.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.95 0.722 . . . . 2.6600000000000001 112.95 -173.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -73.66 -38.82 52.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 110.459 -0.2 . . . . 2.1200000000000001 110.459 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -87.83 -34.7 18.16 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.346 -0.542 . . . . 1.74 111.514 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.971 0.891 . . . . 3.0 110.129 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.125 0.488 . . . . 5.29 111.294 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 ' HB ' ' ND2' ' A' ' 15' ' ' ASN . 44.0 t -83.87 71.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.721 0.772 . . . . 3.0600000000000001 110.104 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.249 1.048 0 CA-C-N 114.553 -1.203 . . . . 3.23 109.371 175.034 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 121.082 0.468 . . . . 3.8199999999999998 110.547 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.7 -23.49 59.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.315 0.579 . . . . 2.9399999999999999 110.447 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HA ' HD21 ' A' ' 8' ' ' ASN . 8.9 p -70.74 -5.32 29.05 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.618 -0.719 . . . . 1.29 111.026 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.54 -27.3 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.748 0.419 . . . . 1.3300000000000001 111.154 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -89.6 16.97 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.606 0.717 . . . . 1.8 109.825 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 5' ' ' CYS . 24.0 m-80 -130.03 102.15 17.67 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.912 -1.04 . . . . 0.42999999999999999 108.731 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.21 -22.13 39.03 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.028 1.819 . . . . 1.1499999999999999 112.305 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.57 -29.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.684 0.754 . . . . 1.9099999999999999 110.394 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -76.68 -43.65 36.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.545 -0.752 . . . . 1.29 110.541 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -16.21 56.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.135 0.791 . . . . 2.6600000000000001 113.135 -171.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.31 -43.61 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.601 0.239 . . . . 2.1200000000000001 111.348 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -80.81 -37.34 30.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.989 0.423 . . . . 1.74 109.961 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.467 HD21 HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 108.681 -0.859 . . . . 3.0 108.681 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.913 0.338 . . . . 5.29 111.913 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 15' ' ' ASN . 35.8 m -76.67 -10.87 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.677 0.751 . . . . 3.0600000000000001 109.395 169.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.468 -1.242 . . . . 3.23 108.852 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 121.009 0.433 . . . . 3.8199999999999998 111.097 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -60.52 -12.66 10.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.6 -0.727 . . . . 2.9399999999999999 110.514 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 m -58.92 -11.73 3.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.653 -0.703 . . . . 1.29 112.757 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.28 -40.84 98.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.725 0.298 . . . . 1.3300000000000001 111.418 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 p -91.87 -8.25 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.229 0.538 . . . . 1.8 110.713 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 23.9 m-80 -97.03 100.63 7.88 Favored Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.567 -0.742 . . . . 0.42999999999999999 109.123 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 19.2 Cg_endo -56.51 -23.27 46.95 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.895 1.73 . . . . 1.1499999999999999 112.552 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 -38.06 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.477 0.656 . . . . 1.9099999999999999 110.378 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.8 m -63.58 -47.67 80.57 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.312 -0.858 . . . . 1.29 110.858 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -71.63 -25.27 62.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 2.6600000000000001 111.971 -172.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -88.78 -25.7 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 112.184 0.439 . . . . 2.1200000000000001 112.184 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -85.14 -36.43 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.532 0.682 . . . . 1.74 109.864 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.56 ' O ' HG11 ' A' ' 18' ' ' VAL . 50.7 t30 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.07 -0.968 . . . . 3.0 109.148 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.93 0.395 . . . . 5.29 110.621 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 ' O ' ' A' ' 15' ' ' ASN . 7.2 p -114.08 76.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.272 1.034 . . . . 3.0600000000000001 110.585 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.157 -0.929 . . . . 3.23 110.095 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.382 0.61 . . . . 3.8199999999999998 109.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.29 9.76 31.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.606 -0.725 . . . . 2.9399999999999999 111.554 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.5 m -61.35 -12.61 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.775 0.322 . . . . 1.29 111.755 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.51 -32.76 74.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.327 -0.397 . . . . 1.3300000000000001 110.401 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -89.18 11.68 18.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.364 0.602 . . . . 1.8 110.277 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.3 m-80 -135.04 97.29 13.72 Favored Pre-proline 0 CA--C 1.508 -0.655 0 CA-C-N 115.574 -0.739 . . . . 0.42999999999999999 109.609 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.81 -18.74 22.52 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.407 2.072 . . . . 1.1499999999999999 113.011 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.75 -42.47 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 1.9099999999999999 110.201 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.83 -35.52 38.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.738 -0.665 . . . . 1.29 111.576 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.0 ptm180 -70.16 -26.37 63.89 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.089 -0.644 . . . . 2.6600000000000001 111.469 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 -58.92 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.704 -0.68 . . . . 2.1200000000000001 112.559 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.15 -44.32 89.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.946 0.403 . . . . 1.74 110.606 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 108.933 -0.766 . . . . 3.0 108.933 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.44 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 50.9 m80 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.355 0.502 . . . . 5.29 112.355 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 17' ' ' HIS . 55.8 t 70.43 -52.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.05 0.54 . . . . 3.0600000000000001 111.224 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 119.003 -0.523 . . . . 3.23 110.339 176.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 6' ' ' CYS . 5.3 p-10 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.597 0.713 . . . . 3.8199999999999998 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.02 -46.96 72.89 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.131 -0.941 . . . . 2.9399999999999999 110.249 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.0 m -65.03 -16.54 63.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.14 -0.482 . . . . 1.29 112.068 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 14.4 m -59.84 -26.37 65.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.806 0.299 . . . . 1.3300000000000001 111.806 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.8 m -93.39 9.52 36.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.551 0.691 . . . . 1.8 110.229 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 25.3 m-80 -127.94 92.54 41.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.339 -0.846 . . . . 0.42999999999999999 109.286 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.35 -24.01 25.96 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.334 2.022 . . . . 1.1499999999999999 112.946 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.506 ' O ' HG11 ' A' ' 13' ' ' VAL . 2.8 p -79.88 -33.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.85 0.833 . . . . 1.9099999999999999 110.172 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t -73.96 -39.67 63.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.301 -0.863 . . . . 1.29 110.11 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.7 ptt180 -83.47 -27.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.752 1.019 . . . . 2.6600000000000001 113.752 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 10' ' ' VAL . 11.3 p -59.68 -37.08 69.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 2.1200000000000001 110.435 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -76.28 -42.79 44.3 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.545 0.688 . . . . 1.74 110.041 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.041 -0.982 . . . . 3.0 109.805 -165.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.391 0.615 . . . . 5.29 109.591 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.76 -29.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.378 -0.828 . . . . 3.0600000000000001 111.666 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.636 -0.697 . . . . 3.23 110.141 -179.149 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 122.126 0.965 . . . . 3.8199999999999998 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.2 -29.7 70.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.111 -1.404 . . . . 2.9399999999999999 110.987 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -17.26 64.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.236 -0.438 . . . . 1.29 111.504 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -61.04 -35.42 76.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.703 0.287 . . . . 1.3300000000000001 111.394 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 t -83.44 -6.4 59.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.669 . . . . 1.8 109.743 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -99.67 107.37 45.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.083 -0.962 . . . . 0.42999999999999999 109.62 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 25.7 Cg_endo -60.55 -18.28 53.54 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.753 1.636 . . . . 1.1499999999999999 112.7 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.4 p -75.58 -31.63 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 1.9099999999999999 110.177 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 46.4 t -72.77 -48.85 34.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.606 -0.725 . . . . 1.29 110.151 177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HA ' HD21 ' A' ' 15' ' ' ASN . 16.7 ptt180 -76.91 -17.79 58.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.282 0.845 . . . . 2.6600000000000001 113.282 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.1 p -75.11 -32.61 26.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.519 0.2 . . . . 2.1200000000000001 110.933 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -102.95 -39.2 7.03 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.545 -0.462 . . . . 1.74 111.84 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.768 0.794 . . . . 3.0 111.182 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.864 0.364 . . . . 5.29 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.9 -41.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.655 -0.498 . . . . 3.0600000000000001 109.655 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.38 -0.819 . . . . 3.23 109.667 176.328 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 121.783 0.802 . . . . 3.8199999999999998 110.054 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.25 -22.73 12.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.278 -0.874 . . . . 2.9399999999999999 110.364 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.73 -5.75 32.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 1.29 111.97 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.19 -36.25 83.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.722 0.296 . . . . 1.3300000000000001 110.789 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -89.51 6.08 42.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.58 0.705 . . . . 1.8 109.64 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.562 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.7 OUTLIER -113.98 91.48 22.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.912 -1.04 . . . . 0.42999999999999999 108.758 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.21 -27.01 45.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.229 1.953 . . . . 1.1499999999999999 112.397 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -47.18 93.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.598 -0.274 . . . . 1.9099999999999999 110.289 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.43 -56.85 16.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.105 -0.498 . . . . 1.29 111.329 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.22 -18.05 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.572 -0.74 . . . . 2.6600000000000001 112.831 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.74 -47.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 112.285 0.476 . . . . 2.1200000000000001 112.285 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.59 -25.2 56.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.29 -0.564 . . . . 1.74 110.457 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.816 -0.629 . . . . 3.0 109.818 -178.39 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.8 m170 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.941 0.401 . . . . 5.29 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.01 -16.26 7.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.58 0.705 . . . . 3.0600000000000001 110.205 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.67 -0.681 . . . . 3.23 109.756 -179.19 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.489 0.661 . . . . 3.8199999999999998 110.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -62.52 -62.8 1.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.525 -0.761 . . . . 2.9399999999999999 111.789 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 m -72.02 -7.7 50.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.29 111.677 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.07 -31.22 68.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.165 -0.471 . . . . 1.3300000000000001 110.709 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -85.32 2.87 42.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.729 0.775 . . . . 1.8 109.822 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -124.0 89.5 51.62 Favored Pre-proline 0 CA--C 1.508 -0.649 0 CA-C-N 114.983 -1.008 . . . . 0.42999999999999999 109.333 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' HG21 ' A' ' 13' ' ' VAL . 50.1 Cg_exo -56.17 -18.88 25.13 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.55 2.167 . . . . 1.1499999999999999 112.803 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.39 -32.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.587 0.708 . . . . 1.9099999999999999 110.305 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.427 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 34.6 t -75.7 -43.47 47.05 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.334 -0.546 . . . . 1.29 109.709 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.654 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 ptm180 -72.83 -17.48 61.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.472 0.915 . . . . 2.6600000000000001 113.472 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 9' ' ' PRO . 8.2 m -82.56 -33.22 10.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.705 -0.225 . . . . 2.1200000000000001 111.404 175.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 p30 -89.61 -33.55 16.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.475 -0.49 . . . . 1.74 111.476 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.242 0.544 . . . . 3.0 111.684 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 . . . . . 0 C--O 1.232 0.174 0 N-CA-C 109.765 -0.457 . . . . 5.29 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 HG23 ' CG ' ' A' ' 15' ' ' ASN . 2.9 m -90.42 3.15 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.257 0.551 . . . . 3.0600000000000001 110.855 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.305 -0.855 . . . . 3.23 109.404 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.312 0.577 . . . . 3.8199999999999998 110.058 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.27 -46.31 2.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.8 -0.636 . . . . 2.9399999999999999 110.856 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.46 -7.03 48.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.122 -0.49 . . . . 1.29 111.3 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' N ' ' HB2' ' A' ' 19' ' ' CYS . 49.9 m -67.3 -25.19 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.465 -0.334 . . . . 1.3300000000000001 111.467 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -90.51 14.47 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 1.8 109.454 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.555 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 23.7 m-80 -130.25 94.74 29.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.107 -0.951 . . . . 0.42999999999999999 109.057 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' O ' HG11 ' A' ' 13' ' ' VAL . 28.7 Cg_endo -60.11 -16.13 37.97 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.362 2.041 . . . . 1.1499999999999999 112.818 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.74 -39.01 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 1.9099999999999999 110.366 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 t -71.57 -35.16 70.48 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.51 -0.476 . . . . 1.29 110.367 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 14.4 ptm180 -82.17 -17.82 44.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.018 1.118 . . . . 2.6600000000000001 114.018 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 9' ' ' PRO . 3.7 m -71.69 -33.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 O-C-N 121.89 -0.506 . . . . 2.1200000000000001 111.045 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.67 -50.77 63.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.228 -0.589 . . . . 1.74 110.121 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 N--CA 1.434 -1.252 0 CA-C-N 115.448 -0.796 . . . . 3.0 111.653 -172.615 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 121.403 0.62 . . . . 5.29 110.468 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.33 69.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.509 -0.923 . . . . 3.0600000000000001 108.509 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 2.1 p . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.036 -0.984 . . . . 3.23 111.585 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.194 0.521 . . . . 3.8199999999999998 110.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.87 -55.14 4.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.802 -0.635 . . . . 2.9399999999999999 110.274 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.6 p -68.34 -10.37 54.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 1.29 110.728 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 34.3 t -63.31 -26.9 68.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 1.3300000000000001 110.697 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -85.48 7.17 23.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.443 0.639 . . . . 1.8 110.1 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.2 m-80 -115.84 114.93 41.59 Favored Pre-proline 0 CA--C 1.513 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.42999999999999999 109.78 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 -15.61 47.99 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.078 1.852 . . . . 1.1499999999999999 112.99 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 13' ' ' VAL . 79.5 t -83.98 -28.35 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 1.9099999999999999 110.475 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 46.6 t -82.36 -44.0 16.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.702 -0.799 . . . . 1.29 110.428 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 13.7 ptt180 -72.13 -17.76 61.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.949 0.722 . . . . 2.6600000000000001 112.949 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -75.43 -40.71 42.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.505 -0.316 . . . . 2.1200000000000001 110.852 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 8.5 p30 -88.06 -30.61 19.79 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.382 -0.527 . . . . 1.74 111.144 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.588 ' CG ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 122.148 0.975 . . . . 3.0 110.628 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 m80 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 111.678 0.251 . . . . 5.29 111.678 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.588 HG13 ' CG ' ' A' ' 15' ' ' ASN . 4.3 p -93.02 -30.98 4.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.667 -0.813 . . . . 3.0600000000000001 108.934 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.1 -0.955 . . . . 3.23 108.694 174.067 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.632 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 5.1 m-20 . . . . . 0 C--O 1.236 0.351 0 CA-C-O 120.928 0.394 . . . . 3.8199999999999998 111.346 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.16 -62.43 1.38 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.946 -0.57 . . . . 2.9399999999999999 110.782 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.9 m -60.15 -25.78 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.446 . . . . 1.29 111.843 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.0 m -62.54 -28.74 70.06 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 1.3300000000000001 111.116 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t -91.45 -5.34 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 1.8 110.22 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.6 m-80 -118.98 102.75 48.84 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-N 115.646 -0.706 . . . . 0.42999999999999999 109.946 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.31 -18.36 37.57 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.169 1.913 . . . . 1.1499999999999999 113.034 -175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 13' ' ' VAL . 9.8 p -80.6 -37.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.519 0.676 . . . . 1.9099999999999999 110.666 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 13.2 t -76.46 -42.27 44.36 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.998 -0.681 . . . . 1.29 110.141 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 12.0 ptm180 -73.38 -26.23 60.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.026 0.75 . . . . 2.6600000000000001 113.026 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -66.95 -40.81 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.696 0.284 . . . . 2.1200000000000001 111.294 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -90.11 -21.9 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 1.74 110.888 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.696 0.76 . . . . 3.0 111.141 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.9 m80 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.204 0.526 . . . . 5.29 111.442 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.56 -42.55 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.009 -0.738 . . . . 3.0600000000000001 109.009 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 3' ' ' ASP . 49.8 t . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.657 -1.156 . . . . 3.23 108.184 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 121.084 0.468 . . . . 3.8199999999999998 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.59 11.7 38.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 2.9399999999999999 111.205 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -68.61 -6.49 26.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.236 -0.438 . . . . 1.29 111.49 -177.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.4 m -60.41 -26.02 66.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 1.3300000000000001 111.099 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -87.03 15.93 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.856 0.836 . . . . 1.8 109.287 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 16.9 m-80 -129.77 97.88 23.21 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 114.728 -1.123 . . . . 0.42999999999999999 108.121 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' O ' HG13 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -54.3 -25.61 39.6 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.197 1.932 . . . . 1.1499999999999999 112.679 -174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -73.76 -35.18 42.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.975 0.417 . . . . 1.9099999999999999 110.396 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -67.98 -40.23 83.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 1.29 110.428 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -82.49 -34.14 28.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.498 0.925 . . . . 2.6600000000000001 113.498 -171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 9' ' ' PRO . 10.7 m -58.82 -48.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 111.749 0.277 . . . . 2.1200000000000001 111.749 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 HD21 ' C ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -91.81 -3.05 56.59 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.716 -0.394 . . . . 1.74 111.961 -176.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 3.0 110.529 179.226 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 m80 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 112.011 0.374 . . . . 5.29 112.011 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 p -58.98 -32.26 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.921 0.391 . . . . 3.0600000000000001 111.09 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 24.5 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.87 -0.586 . . . . 3.23 110.039 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.53 0.681 . . . . 3.8199999999999998 110.621 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.04 -23.93 60.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.754 -1.112 . . . . 2.9399999999999999 110.751 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -64.37 -14.75 58.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.468 0.544 . . . . 1.29 112.468 -172.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.55 -37.82 80.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 1.3300000000000001 110.597 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.8 t -82.71 4.95 22.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.649 0.737 . . . . 1.8 109.8 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.29 107.64 47.01 Favored Pre-proline 0 CA--C 1.509 -0.614 0 CA-C-N 115.12 -0.945 . . . . 0.42999999999999999 109.482 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.58 -20.5 70.92 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.622 1.548 . . . . 1.1499999999999999 111.935 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -73.83 -31.29 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.396 0.617 . . . . 1.9099999999999999 109.639 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 73.9 m -76.19 -56.28 4.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.82 -0.627 . . . . 1.29 110.595 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -19.22 64.67 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.907 0.706 . . . . 2.6600000000000001 112.907 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -89.78 -35.51 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 112.336 0.495 . . . . 2.1200000000000001 112.336 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 2.4 p30 -80.13 -31.13 39.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.131 -0.628 . . . . 1.74 110.063 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 109.328 -0.619 . . . . 3.0 109.328 176.258 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.305 0.574 . . . . 5.29 110.624 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.51 -32.31 49.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.805 -0.634 . . . . 3.0600000000000001 110.169 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.707 -0.663 . . . . 3.23 109.464 175.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.236 0.541 . . . . 3.8199999999999998 111.789 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.8 -20.34 61.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.629 -0.714 . . . . 2.9399999999999999 110.847 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -61.55 -8.2 4.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.153 -0.476 . . . . 1.29 112.084 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.1 -33.32 73.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.995 0.426 . . . . 1.3300000000000001 110.241 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -85.32 1.1 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 1.8 109.719 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -119.52 90.69 43.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.676 -1.147 . . . . 0.42999999999999999 108.771 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.57 ' O ' HG13 ' A' ' 13' ' ' VAL . 18.5 Cg_endo -56.73 -22.16 43.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.134 1.89 . . . . 1.1499999999999999 112.495 -174.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 13' ' ' VAL . 59.8 t -80.67 -31.85 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.522 0.677 . . . . 1.9099999999999999 110.077 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.3 t -76.72 -32.79 58.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.099 -0.5 . . . . 1.29 110.286 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -83.12 -21.56 33.59 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.515 0.932 . . . . 2.6600000000000001 113.515 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 9' ' ' PRO . 16.3 m -72.33 -36.14 54.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 111.76 0.282 . . . . 2.1200000000000001 111.76 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -87.27 -10.05 53.4 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.594 -0.442 . . . . 1.74 110.575 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 115.811 -0.631 . . . . 3.0 109.329 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.044 0.45 . . . . 5.29 110.562 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.734 -0.469 . . . . 3.0600000000000001 109.734 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.253 1.255 0 CA-C-N 115.605 -0.725 . . . . 3.23 109.152 178.231 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 121.206 0.527 . . . . 3.8199999999999998 111.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.0 -14.55 60.63 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.495 -0.775 . . . . 2.9399999999999999 110.065 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.45 -7.6 7.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.016 -0.538 . . . . 1.29 112.408 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.3 m -65.09 -37.2 86.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.484 -0.562 . . . . 1.3300000000000001 109.484 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -87.58 7.23 30.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.635 -0.711 . . . . 1.8 109.98 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -120.7 93.24 48.5 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-N 115.186 -0.915 . . . . 0.42999999999999999 108.925 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.85 -22.78 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.047 1.831 . . . . 1.1499999999999999 112.511 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 11' ' ' CYS . 14.0 p -64.1 -46.89 92.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 1.9099999999999999 110.216 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' N ' HG11 ' A' ' 10' ' ' VAL . 81.0 m -61.72 -55.39 30.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.755 . . . . 1.29 111.154 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -70.38 -16.71 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.158 0.799 . . . . 2.6600000000000001 113.158 -171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.09 -40.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.145 0.424 . . . . 2.1200000000000001 112.145 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.32 -25.11 42.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.915 -0.714 . . . . 1.74 109.755 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.417 ' C ' HD21 ' A' ' 15' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 108.988 -0.745 . . . . 3.0 108.988 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 108.324 -0.991 . . . . 5.29 108.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.55 -29.14 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.274 -0.875 . . . . 3.0600000000000001 110.421 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-N 116.092 -0.503 . . . . 3.23 110.209 175.388 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.669 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.0 t70 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 108.859 -0.793 . . . . 3.8199999999999998 108.859 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.87 -16.38 63.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.363 -0.38 . . . . 2.9399999999999999 111.607 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.669 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -66.82 -10.07 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.29 110.896 177.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.6 t -63.79 -32.41 73.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.124 -0.489 . . . . 1.3300000000000001 110.133 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 t -88.77 17.15 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.538 0.685 . . . . 1.8 110.105 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 27.2 m-80 -132.93 104.68 12.71 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-N 115.579 -0.737 . . . . 0.42999999999999999 109.974 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.9 -24.44 56.62 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.895 1.73 . . . . 1.1499999999999999 112.196 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.44 -33.53 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.828 0.823 . . . . 1.9099999999999999 110.301 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.8 m -73.83 -43.38 58.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.532 -0.758 . . . . 1.29 109.946 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 28.9 mtp180 -68.71 -38.95 80.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.234 -0.894 . . . . 2.6600000000000001 112.898 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.5 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.806 -0.634 . . . . 2.1200000000000001 112.205 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -87.13 -34.49 19.07 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.654 -0.418 . . . . 1.74 111.281 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 121.945 0.879 . . . . 3.0 110.554 178.561 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 CA--C 1.523 -0.058 0 CA-C-O 121.096 0.474 . . . . 5.29 111.399 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.75 -28.04 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.163 0.506 . . . . 3.0600000000000001 110.318 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.732 . . . . 3.23 109.672 176.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.814 -0.439 . . . . 3.8199999999999998 109.814 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.66 -20.29 33.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.116 -0.493 . . . . 2.9399999999999999 110.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -17.74 62.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.29 110.808 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.6 t -59.72 -36.36 76.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 111.323 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -84.16 -6.82 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.433 0.635 . . . . 1.8 109.797 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 24.8 m-80 -99.63 111.61 61.94 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.42999999999999999 110.125 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.88 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.716 1.611 . . . . 1.1499999999999999 112.442 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.91 -42.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.494 0.664 . . . . 1.9099999999999999 110.035 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -69.44 -52.6 25.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 1.29 111.374 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 8.7 ptm180 -64.94 -21.02 66.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.942 0.719 . . . . 2.6600000000000001 112.942 -175.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 t -88.65 -38.52 11.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.035 0.445 . . . . 2.1200000000000001 111.943 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -81.33 -21.2 39.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.431 0.634 . . . . 1.74 110.266 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.45 HD21 ' HB ' ' A' ' 18' ' ' VAL . 6.6 t30 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 109.205 -0.665 . . . . 3.0 109.205 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.794 0.807 . . . . 5.29 108.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HB ' HD21 ' A' ' 15' ' ' ASN . 9.4 p -87.57 -26.16 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.372 -0.831 . . . . 3.0600000000000001 110.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.515 -0.755 . . . . 3.23 109.877 -179.456 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 109.368 -0.605 . . . . 3.8199999999999998 109.368 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.73 -36.83 59.83 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.721 0.296 . . . . 2.9399999999999999 111.204 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 1.1 p -69.1 -8.41 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.766 0.284 . . . . 1.29 111.766 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.16 -28.59 69.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.733 0.301 . . . . 1.3300000000000001 111.283 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.5 p -79.93 4.19 17.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.873 0.844 . . . . 1.8 109.729 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 26.3 m-80 -116.66 106.23 48.6 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.597 -1.183 . . . . 0.42999999999999999 109.392 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.428 ' O ' HG21 ' A' ' 13' ' ' VAL . 52.6 Cg_exo -54.62 -24.18 35.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.198 1.932 . . . . 1.1499999999999999 112.686 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.82 -35.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.9099999999999999 110.794 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.85 -37.56 67.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 1.29 110.326 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.758 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.1 ptm180 -82.2 -18.15 43.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.728 1.01 . . . . 2.6600000000000001 113.728 -172.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 9' ' ' PRO . 10.8 m -78.22 -34.14 18.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 111.519 0.192 . . . . 2.1200000000000001 111.519 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.24 -36.09 14.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.536 -0.465 . . . . 1.74 111.583 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.758 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 120.947 0.403 . . . . 3.0 110.183 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 111.94 0.348 . . . . 5.29 111.94 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.78 -15.68 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.799 0.809 . . . . 3.0600000000000001 108.836 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.0 m . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.791 -1.095 . . . . 3.23 109.58 176.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.5 t70 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 108.713 -0.847 . . . . 3.8199999999999998 108.713 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.8 -26.94 60.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 2.9399999999999999 111.205 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 m -73.62 -8.17 54.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.118 0.414 . . . . 1.29 112.118 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 3' ' ' ASP . 63.5 m -64.97 -37.01 86.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.633 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.6 m -89.06 21.04 3.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.844 0.83 . . . . 1.8 109.75 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -127.31 98.48 29.39 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-N 114.891 -1.05 . . . . 0.42999999999999999 109.13 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.22 -13.74 37.56 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.745 1.63 . . . . 1.1499999999999999 111.793 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 13' ' ' VAL . 84.1 t -78.81 -32.49 15.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.301 0.572 . . . . 1.9099999999999999 110.184 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.6 m -72.17 -51.06 23.0 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.898 0.38 . . . . 1.29 110.196 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.693 ' HB3' ' OXT' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.89 -17.67 60.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.621 0.971 . . . . 2.6600000000000001 113.621 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.1 p -71.09 -38.61 72.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 121.12 -0.232 . . . . 2.1200000000000001 110.612 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.24 -28.2 14.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.293 0.479 . . . . 1.74 112.293 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 30.0 p30 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 122.301 1.048 . . . . 3.0 111.045 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.0 p80 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.821 0.343 . . . . 5.29 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.63 -73.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.41 . . . . 3.0600000000000001 110.702 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.693 ' OXT' ' HB3' ' A' ' 12' ' ' ARG . 50.8 t . . . . . 0 C--O 1.252 1.233 0 N-CA-C 108.864 -0.791 . . . . 3.23 108.864 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 19.2 m-20 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.889 0.376 . . . . 3.8199999999999998 110.979 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -67.22 -56.32 10.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 2.9399999999999999 110.491 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' HD21 ' A' ' 8' ' ' ASN . 1.2 m -67.86 -6.92 23.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 1.29 111.75 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 48.6 t -66.58 -18.89 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.432 0.634 . . . . 1.3300000000000001 110.548 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -101.96 6.52 41.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.696 -0.684 . . . . 1.8 109.759 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 5' ' ' CYS . 20.2 m-80 -117.15 111.1 40.68 Favored Pre-proline 0 CA--C 1.507 -0.698 0 CA-C-N 115.318 -0.856 . . . . 0.42999999999999999 109.14 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.61 -21.54 73.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.782 1.655 . . . . 1.1499999999999999 112.433 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.8 t -80.56 -41.38 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.339 -0.391 . . . . 1.9099999999999999 110.578 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.11 -39.26 81.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.37 0.605 . . . . 1.29 110.665 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 52.3 mtp180 -73.6 -35.18 65.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.957 -1.02 . . . . 2.6600000000000001 112.112 -172.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.87 -22.55 7.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.221 -0.899 . . . . 2.1200000000000001 111.621 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.95 -31.75 20.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.342 0.591 . . . . 1.74 110.119 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.549 -0.751 . . . . 3.0 109.028 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.0 m80 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.281 -0.637 . . . . 5.29 109.281 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.73 -33.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 3.0600000000000001 110.968 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.703 -0.665 . . . . 3.23 109.902 -177.924 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 7.1699999999999999 109.855 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -172.85 47.85 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.6 -1.182 . . . . 8.2200000000000006 108.636 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.98 67.41 7.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.751 . . . . 3.8199999999999998 110.778 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 2.9399999999999999 110.465 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -70.49 -9.01 55.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.693 -0.685 . . . . 1.29 111.798 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 t -64.65 -31.61 72.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.769 0.318 . . . . 1.3300000000000001 110.509 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 t -87.0 20.54 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.601 0.715 . . . . 1.8 109.67 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 30.0 m-80 -132.47 111.36 13.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.178 -0.919 . . . . 0.42999999999999999 109.492 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.43 -13.65 40.91 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.143 1.896 . . . . 1.1499999999999999 112.487 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 13' ' ' VAL . 23.8 t -84.23 -31.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 1.9099999999999999 110.315 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 85.5 m -76.33 -50.28 14.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.652 -0.419 . . . . 1.29 110.243 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 19.9 ptt180 -71.15 -17.01 62.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.95 0.722 . . . . 2.6600000000000001 112.95 -173.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -73.66 -38.82 52.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 110.459 -0.2 . . . . 2.1200000000000001 110.459 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -87.83 -34.7 18.16 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.346 -0.542 . . . . 1.74 111.514 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 18' ' ' VAL . 7.2 p30 -81.0 141.02 34.83 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.971 0.891 . . . . 3.0 110.129 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -163.89 45.22 0.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 5.29 111.294 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 ' HB ' ' ND2' ' A' ' 15' ' ' ASN . 44.0 t -83.87 71.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.721 0.772 . . . . 3.0600000000000001 110.104 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.249 1.048 0 CA-C-N 114.553 -1.203 . . . . 3.23 109.371 175.034 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.767 0.317 . . . . 7.1699999999999999 110.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -138.95 127.91 23.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 110.009 -0.367 . . . . 8.2200000000000006 110.009 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.58 77.2 3.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.082 0.468 . . . . 3.8199999999999998 110.547 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.7 -23.49 59.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.315 0.579 . . . . 2.9399999999999999 110.447 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HA ' HD21 ' A' ' 8' ' ' ASN . 8.9 p -70.74 -5.32 29.05 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.618 -0.719 . . . . 1.29 111.026 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.54 -27.3 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.748 0.419 . . . . 1.3300000000000001 111.154 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -89.6 16.97 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.606 0.717 . . . . 1.8 109.825 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 5' ' ' CYS . 24.0 m-80 -130.03 102.15 17.67 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.912 -1.04 . . . . 0.42999999999999999 108.731 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.21 -22.13 39.03 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.028 1.819 . . . . 1.1499999999999999 112.305 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.57 -29.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.684 0.754 . . . . 1.9099999999999999 110.394 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -76.68 -43.65 36.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.545 -0.752 . . . . 1.29 110.541 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -16.21 56.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.135 0.791 . . . . 2.6600000000000001 113.135 -171.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.31 -43.61 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.601 0.239 . . . . 2.1200000000000001 111.348 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' HD23 ' A' ' 16' ' ' HYP . 4.9 p30 -80.81 -37.34 30.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.989 0.423 . . . . 1.74 109.961 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.467 HD21 HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -94.61 103.62 15.56 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.681 -0.859 . . . . 3.0 108.681 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . 0.425 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 60.22 41.13 17.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.601 -1.182 . . . . 5.29 111.913 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 15' ' ' ASN . 35.8 m -76.67 -10.87 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.677 0.751 . . . . 3.0600000000000001 109.395 169.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.468 -1.242 . . . . 3.23 108.852 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.824 0.345 . . . . 7.1699999999999999 110.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 mmp_? -83.67 140.35 32.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.484 . . . . 8.2200000000000006 109.91 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.26 99.92 10.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 3.8199999999999998 111.097 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -60.52 -12.66 10.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.6 -0.727 . . . . 2.9399999999999999 110.514 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 m -58.92 -11.73 3.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.653 -0.703 . . . . 1.29 112.757 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.28 -40.84 98.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.725 0.298 . . . . 1.3300000000000001 111.418 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 p -91.87 -8.25 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.229 0.538 . . . . 1.8 110.713 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 23.9 m-80 -97.03 100.63 7.88 Favored Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.567 -0.742 . . . . 0.42999999999999999 109.123 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 19.2 Cg_endo -56.51 -23.27 46.95 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.895 1.73 . . . . 1.1499999999999999 112.552 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 -38.06 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.477 0.656 . . . . 1.9099999999999999 110.378 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.8 m -63.58 -47.67 80.57 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.312 -0.858 . . . . 1.29 110.858 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -71.63 -25.27 62.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 2.6600000000000001 111.971 -172.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -88.78 -25.7 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 112.184 0.439 . . . . 2.1200000000000001 112.184 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -85.14 -36.43 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.532 0.682 . . . . 1.74 109.864 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.56 ' O ' HG11 ' A' ' 18' ' ' VAL . 50.7 t30 -140.16 88.31 2.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.07 -0.968 . . . . 3.0 109.148 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -165.67 27.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.606 -0.725 . . . . 5.29 110.621 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG11 ' O ' ' A' ' 15' ' ' ASN . 7.2 p -114.08 76.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.272 1.034 . . . . 3.0600000000000001 110.585 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.157 -0.929 . . . . 3.23 110.095 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.778 -0.452 . . . . 7.1699999999999999 109.778 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -128.3 140.35 51.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.487 -0.561 . . . . 8.2200000000000006 109.487 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -78.67 84.05 4.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 3.8199999999999998 109.938 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.29 9.76 31.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.606 -0.725 . . . . 2.9399999999999999 111.554 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.5 m -61.35 -12.61 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.775 0.322 . . . . 1.29 111.755 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.51 -32.76 74.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.327 -0.397 . . . . 1.3300000000000001 110.401 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -89.18 11.68 18.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.364 0.602 . . . . 1.8 110.277 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.3 m-80 -135.04 97.29 13.72 Favored Pre-proline 0 CA--C 1.508 -0.655 0 CA-C-N 115.574 -0.739 . . . . 0.42999999999999999 109.609 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.81 -18.74 22.52 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.407 2.072 . . . . 1.1499999999999999 113.011 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.75 -42.47 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 1.9099999999999999 110.201 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.83 -35.52 38.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.738 -0.665 . . . . 1.29 111.576 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.0 ptm180 -70.16 -26.37 63.89 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.089 -0.644 . . . . 2.6600000000000001 111.469 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 -58.92 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.704 -0.68 . . . . 2.1200000000000001 112.559 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.15 -44.32 89.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.946 0.403 . . . . 1.74 110.606 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.52 ' ND2' HD22 ' A' ' 16' ' ' HYP . 0.7 OUTLIER -88.51 157.01 18.77 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.933 -0.766 . . . . 3.0 108.933 172.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . 0.52 HD22 ' ND2' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.44 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 50.9 m80 75.29 -47.9 0.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.171 -0.922 . . . . 5.29 112.355 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 17' ' ' HIS . 55.8 t 70.43 -52.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.05 0.54 . . . . 3.0600000000000001 111.224 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 119.003 -0.523 . . . . 3.23 110.339 176.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.554 ' HB ' ' OD1' ' A' ' 3' ' ' ASP . 33.1 pt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.749 0.309 . . . . 7.1699999999999999 110.556 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 2' ' ' ARG . 33.4 mtm180 -102.52 12.04 37.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.465 0.65 . . . . 8.2200000000000006 110.533 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.554 ' OD1' ' HB ' ' A' ' 1' ' ' ILE . 5.3 p-10 -109.72 41.02 1.77 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.121 -0.945 . . . . 3.8199999999999998 111.09 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.02 -46.96 72.89 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.131 -0.941 . . . . 2.9399999999999999 110.249 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.0 m -65.03 -16.54 63.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.14 -0.482 . . . . 1.29 112.068 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 14.4 m -59.84 -26.37 65.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.806 0.299 . . . . 1.3300000000000001 111.806 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.8 m -93.39 9.52 36.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.551 0.691 . . . . 1.8 110.229 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 25.3 m-80 -127.94 92.54 41.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.339 -0.846 . . . . 0.42999999999999999 109.286 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.35 -24.01 25.96 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.334 2.022 . . . . 1.1499999999999999 112.946 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.506 ' O ' HG11 ' A' ' 13' ' ' VAL . 2.8 p -79.88 -33.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.85 0.833 . . . . 1.9099999999999999 110.172 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t -73.96 -39.67 63.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.301 -0.863 . . . . 1.29 110.11 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.7 ptt180 -83.47 -27.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.752 1.019 . . . . 2.6600000000000001 113.752 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 10' ' ' VAL . 11.3 p -59.68 -37.08 69.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 2.1200000000000001 110.435 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -76.28 -42.79 44.3 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.545 0.688 . . . . 1.74 110.041 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -136.09 85.11 2.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.041 -0.982 . . . . 3.0 109.805 -165.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -122.41 35.22 4.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.391 0.615 . . . . 5.29 109.591 172.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.76 -29.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.378 -0.828 . . . . 3.0600000000000001 111.666 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.636 -0.697 . . . . 3.23 110.141 -179.149 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.8 tt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.747 0.308 . . . . 7.1699999999999999 110.369 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -80.75 88.72 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.096 0.475 . . . . 8.2200000000000006 110.081 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -13.76 61.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.126 0.965 . . . . 3.8199999999999998 110.385 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.2 -29.7 70.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.111 -1.404 . . . . 2.9399999999999999 110.987 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -17.26 64.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.236 -0.438 . . . . 1.29 111.504 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -61.04 -35.42 76.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.703 0.287 . . . . 1.3300000000000001 111.394 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 t -83.44 -6.4 59.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.669 . . . . 1.8 109.743 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -99.67 107.37 45.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.083 -0.962 . . . . 0.42999999999999999 109.62 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 25.7 Cg_endo -60.55 -18.28 53.54 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.753 1.636 . . . . 1.1499999999999999 112.7 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.4 p -75.58 -31.63 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 1.9099999999999999 110.177 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 46.4 t -72.77 -48.85 34.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.606 -0.725 . . . . 1.29 110.151 177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HA ' HD21 ' A' ' 15' ' ' ASN . 16.7 ptt180 -76.91 -17.79 58.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.282 0.845 . . . . 2.6600000000000001 113.282 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' VAL . 12.1 p -75.11 -32.61 26.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.519 0.2 . . . . 2.1200000000000001 110.933 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -102.95 -39.2 7.03 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.545 -0.462 . . . . 1.74 111.84 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -70.19 144.5 51.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.768 0.794 . . . . 3.0 111.182 -177.041 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -147.29 48.5 1.12 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 5.29 110.776 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.9 -41.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.655 -0.498 . . . . 3.0600000000000001 109.655 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.38 -0.819 . . . . 3.23 109.667 176.328 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.2 pt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.934 0.397 . . . . 7.1699999999999999 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -157.27 -175.6 5.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.138 -0.483 . . . . 8.2200000000000006 109.844 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 58.31 32.8 22.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.783 0.802 . . . . 3.8199999999999998 110.054 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.25 -22.73 12.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.278 -0.874 . . . . 2.9399999999999999 110.364 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.73 -5.75 32.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 1.29 111.97 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.19 -36.25 83.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.722 0.296 . . . . 1.3300000000000001 110.789 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -89.51 6.08 42.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.58 0.705 . . . . 1.8 109.64 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.7 OUTLIER -113.98 91.48 22.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.912 -1.04 . . . . 0.42999999999999999 108.758 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.21 -27.01 45.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.229 1.953 . . . . 1.1499999999999999 112.397 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -47.18 93.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.598 -0.274 . . . . 1.9099999999999999 110.289 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.43 -56.85 16.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.105 -0.498 . . . . 1.29 111.329 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -65.22 -18.05 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.572 -0.74 . . . . 2.6600000000000001 112.831 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.74 -47.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 112.285 0.476 . . . . 2.1200000000000001 112.285 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.59 -25.2 56.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.29 -0.564 . . . . 1.74 110.457 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -134.98 89.48 2.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.816 -0.629 . . . . 3.0 109.818 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -144.41 18.32 1.7 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.135 -0.484 . . . . 5.29 110.468 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.01 -16.26 7.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.58 0.705 . . . . 3.0600000000000001 110.205 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.67 -0.681 . . . . 3.23 109.756 -179.19 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.284 -0.265 . . . . 7.1699999999999999 110.284 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -79.0 127.11 31.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 8.2200000000000006 110.262 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -92.94 15.21 15.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.489 0.661 . . . . 3.8199999999999998 110.533 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -62.52 -62.8 1.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.525 -0.761 . . . . 2.9399999999999999 111.789 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 m -72.02 -7.7 50.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.29 111.677 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.07 -31.22 68.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.165 -0.471 . . . . 1.3300000000000001 110.709 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -85.32 2.87 42.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.729 0.775 . . . . 1.8 109.822 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -124.0 89.5 51.62 Favored Pre-proline 0 CA--C 1.508 -0.649 0 CA-C-N 114.983 -1.008 . . . . 0.42999999999999999 109.333 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' HG21 ' A' ' 13' ' ' VAL . 50.1 Cg_exo -56.17 -18.88 25.13 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.55 2.167 . . . . 1.1499999999999999 112.803 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.39 -32.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.587 0.708 . . . . 1.9099999999999999 110.305 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.427 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 34.6 t -75.7 -43.47 47.05 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.334 -0.546 . . . . 1.29 109.709 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.654 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 ptm180 -72.83 -17.48 61.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.472 0.915 . . . . 2.6600000000000001 113.472 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 9' ' ' PRO . 8.2 m -82.56 -33.22 10.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.705 -0.225 . . . . 2.1200000000000001 111.404 175.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 p30 -89.61 -33.55 16.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.475 -0.49 . . . . 1.74 111.476 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -65.08 154.61 37.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.242 0.544 . . . . 3.0 111.684 -177.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -148.36 46.82 1.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.103 -0.499 . . . . 5.29 109.765 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 HG23 ' CG ' ' A' ' 15' ' ' ASN . 2.9 m -90.42 3.15 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.257 0.551 . . . . 3.0600000000000001 110.855 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.305 -0.855 . . . . 3.23 109.404 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 35.0 pt . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.043 0.449 . . . . 7.1699999999999999 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -113.24 68.26 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.053 -0.521 . . . . 8.2200000000000006 110.204 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.91 79.56 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.763 -0.653 . . . . 3.8199999999999998 110.058 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.27 -46.31 2.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.8 -0.636 . . . . 2.9399999999999999 110.856 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.46 -7.03 48.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.122 -0.49 . . . . 1.29 111.3 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' N ' ' HB2' ' A' ' 19' ' ' CYS . 49.9 m -67.3 -25.19 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.465 -0.334 . . . . 1.3300000000000001 111.467 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -90.51 14.47 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 1.8 109.454 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.555 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 23.7 m-80 -130.25 94.74 29.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.107 -0.951 . . . . 0.42999999999999999 109.057 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' O ' HG11 ' A' ' 13' ' ' VAL . 28.7 Cg_endo -60.11 -16.13 37.97 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.362 2.041 . . . . 1.1499999999999999 112.818 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.74 -39.01 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 1.9099999999999999 110.366 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 t -71.57 -35.16 70.48 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.51 -0.476 . . . . 1.29 110.367 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 14.4 ptm180 -82.17 -17.82 44.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.018 1.118 . . . . 2.6600000000000001 114.018 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 9' ' ' PRO . 3.7 m -71.69 -33.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 O-C-N 121.89 -0.506 . . . . 2.1200000000000001 111.045 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.67 -50.77 63.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.228 -0.589 . . . . 1.74 110.121 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -81.57 158.41 24.41 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.448 -0.796 . . . . 3.0 111.653 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 72.23 12.59 5.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.559 -0.746 . . . . 5.29 110.468 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.33 69.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.509 -0.923 . . . . 3.0600000000000001 108.509 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 2.1 p . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.036 -0.984 . . . . 3.23 111.585 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.892 -0.41 . . . . 7.1699999999999999 109.892 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -84.43 115.3 22.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.643 -0.502 . . . . 8.2200000000000006 109.643 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -82.23 57.93 3.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.194 0.521 . . . . 3.8199999999999998 110.208 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.87 -55.14 4.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.802 -0.635 . . . . 2.9399999999999999 110.274 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.6 p -68.34 -10.37 54.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 1.29 110.728 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 34.3 t -63.31 -26.9 68.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 1.3300000000000001 110.697 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -85.48 7.17 23.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.443 0.639 . . . . 1.8 110.1 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.2 m-80 -115.84 114.93 41.59 Favored Pre-proline 0 CA--C 1.513 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.42999999999999999 109.78 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 -15.61 47.99 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.078 1.852 . . . . 1.1499999999999999 112.99 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 13' ' ' VAL . 79.5 t -83.98 -28.35 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 1.9099999999999999 110.475 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 46.6 t -82.36 -44.0 16.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.702 -0.799 . . . . 1.29 110.428 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 13.7 ptt180 -72.13 -17.76 61.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.949 0.722 . . . . 2.6600000000000001 112.949 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -75.43 -40.71 42.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.505 -0.316 . . . . 2.1200000000000001 110.852 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 8.5 p30 -88.06 -30.61 19.79 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.382 -0.527 . . . . 1.74 111.144 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.588 ' CG ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -67.99 132.71 47.8 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.148 0.975 . . . . 3.0 110.628 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -154.14 49.38 0.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.037 -0.529 . . . . 5.29 111.678 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.588 HG13 ' CG ' ' A' ' 15' ' ' ASN . 4.3 p -93.02 -30.98 4.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.667 -0.813 . . . . 3.0600000000000001 108.934 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.1 -0.955 . . . . 3.23 108.694 174.067 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.674 0.75 . . . . 7.1699999999999999 110.895 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 5.1 mmp_? -136.45 41.93 2.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.202 -0.908 . . . . 8.2200000000000006 108.911 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.632 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 5.1 m-20 -94.14 50.18 1.37 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.132 -0.94 . . . . 3.8199999999999998 111.346 -169.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.16 -62.43 1.38 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.946 -0.57 . . . . 2.9399999999999999 110.782 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.9 m -60.15 -25.78 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.446 . . . . 1.29 111.843 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.0 m -62.54 -28.74 70.06 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 1.3300000000000001 111.116 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t -91.45 -5.34 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 1.8 110.22 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.6 m-80 -118.98 102.75 48.84 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-N 115.646 -0.706 . . . . 0.42999999999999999 109.946 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.31 -18.36 37.57 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.169 1.913 . . . . 1.1499999999999999 113.034 -175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 13' ' ' VAL . 9.8 p -80.6 -37.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.519 0.676 . . . . 1.9099999999999999 110.666 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 13.2 t -76.46 -42.27 44.36 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.998 -0.681 . . . . 1.29 110.141 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 12.0 ptm180 -73.38 -26.23 60.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.026 0.75 . . . . 2.6600000000000001 113.026 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -66.95 -40.81 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.696 0.284 . . . . 2.1200000000000001 111.294 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -90.11 -21.9 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 1.74 110.888 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -69.64 138.76 53.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.696 0.76 . . . . 3.0 111.141 -177.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . 0.42 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.9 m80 60.86 42.9 12.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 5.29 111.442 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.56 -42.55 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.009 -0.738 . . . . 3.0600000000000001 109.009 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 3' ' ' ASP . 49.8 t . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.657 -1.156 . . . . 3.23 108.184 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.993 -0.373 . . . . 7.1699999999999999 109.993 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -128.67 30.3 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 8.2200000000000006 110.877 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -93.15 98.7 11.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 3.8199999999999998 110.211 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.59 11.7 38.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 2.9399999999999999 111.205 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -68.61 -6.49 26.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.236 -0.438 . . . . 1.29 111.49 -177.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.4 m -60.41 -26.02 66.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 1.3300000000000001 111.099 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -87.03 15.93 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.856 0.836 . . . . 1.8 109.287 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 16.9 m-80 -129.77 97.88 23.21 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 114.728 -1.123 . . . . 0.42999999999999999 108.121 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' O ' HG13 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -54.3 -25.61 39.6 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.197 1.932 . . . . 1.1499999999999999 112.679 -174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -73.76 -35.18 42.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.975 0.417 . . . . 1.9099999999999999 110.396 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -67.98 -40.23 83.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 1.29 110.428 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -82.49 -34.14 28.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.498 0.925 . . . . 2.6600000000000001 113.498 -171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 9' ' ' PRO . 10.7 m -58.82 -48.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 111.749 0.277 . . . . 2.1200000000000001 111.749 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 HD21 ' C ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -91.81 -3.05 56.59 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.716 -0.394 . . . . 1.74 111.961 -176.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -159.39 92.04 1.04 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 3.0 110.529 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -118.15 -32.28 4.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.011 0.374 . . . . 5.29 112.011 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 p -58.98 -32.26 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.921 0.391 . . . . 3.0600000000000001 111.09 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 24.5 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.87 -0.586 . . . . 3.23 110.039 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.648 0.261 . . . . 7.1699999999999999 110.766 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -160.18 47.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 8.2200000000000006 109.367 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.51 -3.15 32.46 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.595 -0.729 . . . . 3.8199999999999998 110.621 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.04 -23.93 60.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.754 -1.112 . . . . 2.9399999999999999 110.751 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -64.37 -14.75 58.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.468 0.544 . . . . 1.29 112.468 -172.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.55 -37.82 80.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 1.3300000000000001 110.597 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.8 t -82.71 4.95 22.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.649 0.737 . . . . 1.8 109.8 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.29 107.64 47.01 Favored Pre-proline 0 CA--C 1.509 -0.614 0 CA-C-N 115.12 -0.945 . . . . 0.42999999999999999 109.482 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.58 -20.5 70.92 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.622 1.548 . . . . 1.1499999999999999 111.935 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -73.83 -31.29 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.396 0.617 . . . . 1.9099999999999999 109.639 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 73.9 m -76.19 -56.28 4.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.82 -0.627 . . . . 1.29 110.595 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -19.22 64.67 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.907 0.706 . . . . 2.6600000000000001 112.907 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -89.78 -35.51 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 112.336 0.495 . . . . 2.1200000000000001 112.336 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 2.4 p30 -80.13 -31.13 39.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.131 -0.628 . . . . 1.74 110.063 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -84.41 160.27 20.65 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 109.328 -0.619 . . . . 3.0 109.328 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 58.73 57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.726 . . . . 5.29 110.624 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.51 -32.31 49.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.805 -0.634 . . . . 3.0600000000000001 110.169 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.707 -0.663 . . . . 3.23 109.464 175.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.059 -0.348 . . . . 7.1699999999999999 110.059 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -71.7 129.77 39.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.67 -0.493 . . . . 8.2200000000000006 109.67 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.29 40.73 1.26 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.236 0.541 . . . . 3.8199999999999998 111.789 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.8 -20.34 61.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.629 -0.714 . . . . 2.9399999999999999 110.847 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -61.55 -8.2 4.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.153 -0.476 . . . . 1.29 112.084 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.1 -33.32 73.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.995 0.426 . . . . 1.3300000000000001 110.241 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -85.32 1.1 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 1.8 109.719 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -119.52 90.69 43.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.676 -1.147 . . . . 0.42999999999999999 108.771 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.57 ' O ' HG13 ' A' ' 13' ' ' VAL . 18.5 Cg_endo -56.73 -22.16 43.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.134 1.89 . . . . 1.1499999999999999 112.495 -174.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 13' ' ' VAL . 59.8 t -80.67 -31.85 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.522 0.677 . . . . 1.9099999999999999 110.077 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.3 t -76.72 -32.79 58.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.099 -0.5 . . . . 1.29 110.286 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -83.12 -21.56 33.59 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.515 0.932 . . . . 2.6600000000000001 113.515 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 9' ' ' PRO . 16.3 m -72.33 -36.14 54.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 111.76 0.282 . . . . 2.1200000000000001 111.76 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -87.27 -10.05 53.4 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.594 -0.442 . . . . 1.74 110.575 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -136.3 79.97 1.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.811 -0.631 . . . . 3.0 109.329 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -147.24 13.36 1.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.044 0.45 . . . . 5.29 110.562 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.734 -0.469 . . . . 3.0600000000000001 109.734 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.253 1.255 0 CA-C-N 115.605 -0.725 . . . . 3.23 109.152 178.231 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.3 pt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.298 -0.26 . . . . 7.1699999999999999 110.298 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -80.24 97.53 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.011 0.434 . . . . 8.2200000000000006 110.064 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.26 0.47 14.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.206 0.527 . . . . 3.8199999999999998 111.508 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.0 -14.55 60.63 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.495 -0.775 . . . . 2.9399999999999999 110.065 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.45 -7.6 7.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.016 -0.538 . . . . 1.29 112.408 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.3 m -65.09 -37.2 86.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.484 -0.562 . . . . 1.3300000000000001 109.484 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -87.58 7.23 30.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.635 -0.711 . . . . 1.8 109.98 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -120.7 93.24 48.5 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-N 115.186 -0.915 . . . . 0.42999999999999999 108.925 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.85 -22.78 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.047 1.831 . . . . 1.1499999999999999 112.511 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 11' ' ' CYS . 14.0 p -64.1 -46.89 92.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 1.9099999999999999 110.216 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' N ' HG11 ' A' ' 10' ' ' VAL . 81.0 m -61.72 -55.39 30.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.755 . . . . 1.29 111.154 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -70.38 -16.71 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.158 0.799 . . . . 2.6600000000000001 113.158 -171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.09 -40.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.145 0.424 . . . . 2.1200000000000001 112.145 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.32 -25.11 42.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.915 -0.714 . . . . 1.74 109.755 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' C ' HD21 ' A' ' 15' ' ' ASN . 0.2 OUTLIER -140.68 90.41 2.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.988 -0.745 . . . . 3.0 108.988 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -166.86 28.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.911 -1.04 . . . . 5.29 108.324 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.55 -29.14 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.274 -0.875 . . . . 3.0600000000000001 110.421 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-N 116.092 -0.503 . . . . 3.23 110.209 175.388 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 110.426 -0.212 . . . . 7.1699999999999999 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 64.94 173.77 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.813 0.816 . . . . 8.2200000000000006 112.367 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.669 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.0 t70 -148.92 126.05 11.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.12 -0.945 . . . . 3.8199999999999998 108.859 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.87 -16.38 63.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.363 -0.38 . . . . 2.9399999999999999 111.607 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.669 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -66.82 -10.07 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.29 110.896 177.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.6 t -63.79 -32.41 73.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.124 -0.489 . . . . 1.3300000000000001 110.133 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 t -88.77 17.15 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.538 0.685 . . . . 1.8 110.105 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 27.2 m-80 -132.93 104.68 12.71 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-N 115.579 -0.737 . . . . 0.42999999999999999 109.974 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.9 -24.44 56.62 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.895 1.73 . . . . 1.1499999999999999 112.196 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.44 -33.53 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.828 0.823 . . . . 1.9099999999999999 110.301 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.8 m -73.83 -43.38 58.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.532 -0.758 . . . . 1.29 109.946 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 28.9 mtp180 -68.71 -38.95 80.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.234 -0.894 . . . . 2.6600000000000001 112.898 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.5 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.806 -0.634 . . . . 2.1200000000000001 112.205 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -87.13 -34.49 19.07 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.654 -0.418 . . . . 1.74 111.281 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -88.0 141.59 28.45 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.945 0.879 . . . . 3.0 110.554 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -159.76 55.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 5.29 111.399 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.75 -28.04 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.163 0.506 . . . . 3.0600000000000001 110.318 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.732 . . . . 3.23 109.672 176.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 19' ' ' CYS . 5.2 mp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.703 -0.48 . . . . 7.1699999999999999 109.703 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -82.59 62.11 6.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.197 0.522 . . . . 8.2200000000000006 110.73 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -149.04 123.79 9.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.626 -0.715 . . . . 3.8199999999999998 109.814 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.66 -20.29 33.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.116 -0.493 . . . . 2.9399999999999999 110.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -17.74 62.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.29 110.808 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.6 t -59.72 -36.36 76.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 111.323 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -84.16 -6.82 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.433 0.635 . . . . 1.8 109.797 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 24.8 m-80 -99.63 111.61 61.94 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.42999999999999999 110.125 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.88 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.716 1.611 . . . . 1.1499999999999999 112.442 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.91 -42.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.494 0.664 . . . . 1.9099999999999999 110.035 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -69.44 -52.6 25.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 1.29 111.374 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 8.7 ptm180 -64.94 -21.02 66.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.942 0.719 . . . . 2.6600000000000001 112.942 -175.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 t -88.65 -38.52 11.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.035 0.445 . . . . 2.1200000000000001 111.943 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -81.33 -21.2 39.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.431 0.634 . . . . 1.74 110.266 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.45 HD21 ' HB ' ' A' ' 18' ' ' VAL . 6.6 t30 -144.07 85.93 1.83 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.205 -0.665 . . . . 3.0 109.205 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -150.13 30.98 0.69 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.794 0.807 . . . . 5.29 108.911 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HB ' HD21 ' A' ' 15' ' ' ASN . 9.4 p -87.57 -26.16 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.372 -0.831 . . . . 3.0600000000000001 110.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 1' ' ' ILE . 23.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.515 -0.755 . . . . 3.23 109.877 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.3 pt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.033 0.445 . . . . 7.1699999999999999 111.642 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -115.2 129.39 56.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.695 -0.483 . . . . 8.2200000000000006 109.695 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.22 -165.74 1.12 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.368 -0.605 . . . . 3.8199999999999998 109.368 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.73 -36.83 59.83 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.721 0.296 . . . . 2.9399999999999999 111.204 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 1.1 p -69.1 -8.41 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.766 0.284 . . . . 1.29 111.766 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.16 -28.59 69.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.733 0.301 . . . . 1.3300000000000001 111.283 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.5 p -79.93 4.19 17.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.873 0.844 . . . . 1.8 109.729 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 26.3 m-80 -116.66 106.23 48.6 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.597 -1.183 . . . . 0.42999999999999999 109.392 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.428 ' O ' HG21 ' A' ' 13' ' ' VAL . 52.6 Cg_exo -54.62 -24.18 35.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.198 1.932 . . . . 1.1499999999999999 112.686 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.82 -35.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.9099999999999999 110.794 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.85 -37.56 67.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 1.29 110.326 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.758 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.1 ptm180 -82.2 -18.15 43.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.728 1.01 . . . . 2.6600000000000001 113.728 -172.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 9' ' ' PRO . 10.8 m -78.22 -34.14 18.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 111.519 0.192 . . . . 2.1200000000000001 111.519 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.24 -36.09 14.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.536 -0.465 . . . . 1.74 111.583 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.758 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.66 157.47 30.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.947 0.403 . . . . 3.0 110.183 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 54.96 45.55 26.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.666 . . . . 5.29 111.94 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.78 -15.68 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.799 0.809 . . . . 3.0600000000000001 108.836 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.0 m . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.791 -1.095 . . . . 3.23 109.58 176.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.64 0.257 . . . . 7.1699999999999999 110.681 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.0 77.14 1.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.217 0.532 . . . . 8.2200000000000006 110.01 174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.5 t70 -154.83 129.89 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.713 -0.847 . . . . 3.8199999999999998 108.713 176.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.8 -26.94 60.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 2.9399999999999999 111.205 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 m -73.62 -8.17 54.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.118 0.414 . . . . 1.29 112.118 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 3' ' ' ASP . 63.5 m -64.97 -37.01 86.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.633 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.6 m -89.06 21.04 3.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.844 0.83 . . . . 1.8 109.75 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -127.31 98.48 29.39 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-N 114.891 -1.05 . . . . 0.42999999999999999 109.13 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.22 -13.74 37.56 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.745 1.63 . . . . 1.1499999999999999 111.793 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 13' ' ' VAL . 84.1 t -78.81 -32.49 15.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.301 0.572 . . . . 1.9099999999999999 110.184 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.6 m -72.17 -51.06 23.0 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.898 0.38 . . . . 1.29 110.196 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.693 ' HB3' ' OXT' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.89 -17.67 60.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.621 0.971 . . . . 2.6600000000000001 113.621 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 10' ' ' VAL . 7.1 p -71.09 -38.61 72.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 121.12 -0.232 . . . . 2.1200000000000001 110.612 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.24 -28.2 14.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.293 0.479 . . . . 1.74 112.293 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 30.0 p30 -68.64 139.03 55.46 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.301 1.048 . . . . 3.0 111.045 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -156.93 39.82 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 5.29 111.357 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.63 -73.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.41 . . . . 3.0600000000000001 110.702 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.693 ' OXT' ' HB3' ' A' ' 12' ' ' ARG . 50.8 t . . . . . 0 C--O 1.252 1.233 0 N-CA-C 108.864 -0.791 . . . . 3.23 108.864 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.788 0.327 . . . . 7.1699999999999999 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -120.81 37.95 4.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.342 0.592 . . . . 8.2200000000000006 110.584 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 19.2 m-20 -98.49 30.79 3.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.941 -0.572 . . . . 3.8199999999999998 110.979 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -67.22 -56.32 10.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 2.9399999999999999 110.491 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' HD21 ' A' ' 8' ' ' ASN . 1.2 m -67.86 -6.92 23.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 1.29 111.75 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 48.6 t -66.58 -18.89 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.432 0.634 . . . . 1.3300000000000001 110.548 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -101.96 6.52 41.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.696 -0.684 . . . . 1.8 109.759 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 5' ' ' CYS . 20.2 m-80 -117.15 111.1 40.68 Favored Pre-proline 0 CA--C 1.507 -0.698 0 CA-C-N 115.318 -0.856 . . . . 0.42999999999999999 109.14 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.61 -21.54 73.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.782 1.655 . . . . 1.1499999999999999 112.433 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.8 t -80.56 -41.38 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.339 -0.391 . . . . 1.9099999999999999 110.578 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.11 -39.26 81.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.37 0.605 . . . . 1.29 110.665 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 52.3 mtp180 -73.6 -35.18 65.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.957 -1.02 . . . . 2.6600000000000001 112.112 -172.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.87 -22.55 7.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.221 -0.899 . . . . 2.1200000000000001 111.621 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.95 -31.75 20.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.342 0.591 . . . . 1.74 110.119 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -136.8 85.24 2.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.549 -0.751 . . . . 3.0 109.028 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -139.01 56.14 1.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.516 -0.766 . . . . 5.29 109.281 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.73 -33.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 3.0600000000000001 110.968 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.703 -0.665 . . . . 3.23 109.902 -177.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.936 0.398 . . . . 3.82 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 2.94 110.465 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -70.49 -9.01 55.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.693 -0.685 . . . . 1.15 111.798 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 t -64.65 -31.61 72.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.769 0.318 . . . . 1.33 110.509 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 t -87.0 20.54 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.601 0.715 . . . . 1.24 109.67 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 15.5 m120 -132.47 111.36 13.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.178 -0.919 . . . . 0.43 109.492 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.43 -13.65 40.91 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.143 1.896 . . . . 0.67 112.487 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 13' ' ' VAL . 23.8 t -84.23 -31.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 1.26 110.315 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 85.5 m -76.33 -50.28 14.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.652 -0.419 . . . . 1.29 110.243 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 19.9 ptt180 -71.15 -17.01 62.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.95 0.722 . . . . 2.15 112.95 -173.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -73.66 -38.82 52.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 110.459 -0.2 . . . . 1.52 110.459 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -87.83 -34.7 18.16 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.346 -0.542 . . . . 1.71 111.514 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.971 0.891 . . . . 2.56 110.129 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.125 0.488 . . . . 4.56 111.294 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.467 ' HB ' ' ND2' ' A' ' 15' ' ' ASN . 44.0 t -83.87 71.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.721 0.772 . . . . 2.52 110.104 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.249 1.048 0 CA-C-N 114.553 -1.203 . . . . 3.23 109.371 175.034 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 121.082 0.468 . . . . 3.82 110.547 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.7 -23.49 59.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.315 0.579 . . . . 2.94 110.447 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.9 p -70.74 -5.32 29.05 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.618 -0.719 . . . . 1.15 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.54 -27.3 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.748 0.419 . . . . 1.33 111.154 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -89.6 16.97 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.606 0.717 . . . . 1.24 109.825 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -130.03 102.15 17.67 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.731 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.8 Cg_exo -56.21 -22.13 39.03 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.028 1.819 . . . . 0.67 112.305 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.57 -29.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.684 0.754 . . . . 1.26 110.394 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -76.68 -43.65 36.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.545 -0.752 . . . . 1.29 110.541 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -79.64 -16.21 56.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.135 0.791 . . . . 2.15 113.135 -171.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' PRO . 11.0 m -75.31 -43.61 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.601 0.239 . . . . 1.52 111.348 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -80.81 -37.34 30.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.989 0.423 . . . . 1.71 109.961 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 108.681 -0.859 . . . . 2.56 108.681 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.913 0.338 . . . . 4.56 111.913 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.67 -10.87 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.677 0.751 . . . . 2.52 109.395 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.468 -1.242 . . . . 3.23 108.852 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 121.009 0.433 . . . . 3.82 111.097 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -60.52 -12.66 10.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.6 -0.727 . . . . 2.94 110.514 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 m -58.92 -11.73 3.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.653 -0.703 . . . . 1.15 112.757 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.28 -40.84 98.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.725 0.298 . . . . 1.33 111.418 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 p -91.87 -8.25 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.229 0.538 . . . . 1.24 110.713 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 23.9 m-80 -97.03 100.63 7.88 Favored Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.567 -0.742 . . . . 0.43 109.123 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 19.2 Cg_endo -56.51 -23.27 46.95 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.895 1.73 . . . . 0.67 112.552 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 -38.06 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.477 0.656 . . . . 1.26 110.378 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.8 m -63.58 -47.67 80.57 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.312 -0.858 . . . . 1.29 110.858 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG3' ' HA ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -71.63 -25.27 62.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 2.15 111.971 -172.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 9' ' ' PRO . 18.5 m -88.78 -25.7 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 112.184 0.439 . . . . 1.52 112.184 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -85.14 -36.43 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.532 0.682 . . . . 1.71 109.864 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HG12 ' A' ' 18' ' ' VAL . 2.5 t-20 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.07 -0.968 . . . . 2.56 109.148 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.411 ' CE1' HD22 ' A' ' 15' ' ' ASN . 7.7 p-80 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.93 0.395 . . . . 4.56 110.621 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 15' ' ' ASN . 7.2 p -114.08 76.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.272 1.034 . . . . 2.52 110.585 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.157 -0.929 . . . . 3.23 110.095 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.382 0.61 . . . . 3.82 109.938 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.29 9.76 31.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.606 -0.725 . . . . 2.94 111.554 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.5 m -61.35 -12.61 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.775 0.322 . . . . 1.15 111.755 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.51 -32.76 74.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.327 -0.397 . . . . 1.33 110.401 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -89.18 11.68 18.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.364 0.602 . . . . 1.24 110.277 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.3 m-80 -135.04 97.29 13.72 Favored Pre-proline 0 CA--C 1.508 -0.655 0 CA-C-N 115.574 -0.739 . . . . 0.43 109.609 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.81 -18.74 22.52 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.407 2.072 . . . . 0.67 113.011 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.75 -42.47 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 1.26 110.201 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.83 -35.52 38.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.738 -0.665 . . . . 1.29 111.576 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.0 ptm180 -70.16 -26.37 63.89 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.089 -0.644 . . . . 2.15 111.469 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 -58.92 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.704 -0.68 . . . . 1.52 112.559 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.15 -44.32 89.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.946 0.403 . . . . 1.71 110.606 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.452 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 108.933 -0.766 . . . . 2.56 108.933 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 50.9 m80 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.355 0.502 . . . . 4.56 112.355 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 15' ' ' ASN . 55.8 t 70.43 -52.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.05 0.54 . . . . 2.52 111.224 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 119.003 -0.523 . . . . 3.23 110.339 176.745 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 6' ' ' CYS . 5.3 p-10 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.597 0.713 . . . . 3.82 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.02 -46.96 72.89 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.131 -0.941 . . . . 2.94 110.249 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.0 m -65.03 -16.54 63.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.14 -0.482 . . . . 1.15 112.068 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 14.4 m -59.84 -26.37 65.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.806 0.299 . . . . 1.33 111.806 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.8 m -93.39 9.52 36.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.551 0.691 . . . . 1.24 110.229 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 14.1 m120 -127.94 92.54 41.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.339 -0.846 . . . . 0.43 109.286 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.35 -24.01 25.96 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.334 2.022 . . . . 0.67 112.946 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.8 p -79.88 -33.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.85 0.833 . . . . 1.26 110.172 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t -73.96 -39.67 63.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.301 -0.863 . . . . 1.29 110.11 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.7 ptt180 -83.47 -27.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.752 1.019 . . . . 2.15 113.752 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 10' ' ' VAL . 11.3 p -59.68 -37.08 69.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 1.52 110.435 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -76.28 -42.79 44.3 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.545 0.688 . . . . 1.71 110.041 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.041 -0.982 . . . . 2.56 109.805 -165.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.391 0.615 . . . . 4.56 109.591 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.76 -29.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.378 -0.828 . . . . 2.52 111.666 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.636 -0.697 . . . . 3.23 110.141 -179.149 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 122.126 0.965 . . . . 3.82 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.2 -29.7 70.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.111 -1.404 . . . . 2.94 110.987 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -17.26 64.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.504 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -61.04 -35.42 76.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.703 0.287 . . . . 1.33 111.394 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 t -83.44 -6.4 59.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.669 . . . . 1.24 109.743 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -99.67 107.37 45.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.083 -0.962 . . . . 0.43 109.62 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 25.7 Cg_endo -60.55 -18.28 53.54 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.753 1.636 . . . . 0.67 112.7 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.4 p -75.58 -31.63 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 1.26 110.177 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 46.4 t -72.77 -48.85 34.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.606 -0.725 . . . . 1.29 110.151 177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HA ' HD22 ' A' ' 15' ' ' ASN . 16.7 ptt180 -76.91 -17.79 58.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.282 0.845 . . . . 2.15 113.282 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 10' ' ' VAL . 12.1 p -75.11 -32.61 26.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.519 0.2 . . . . 1.52 110.933 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -102.95 -39.2 7.03 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.545 -0.462 . . . . 1.71 111.84 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.569 HD22 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.768 0.794 . . . . 2.56 111.182 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.864 0.364 . . . . 4.56 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.9 -41.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.38 -0.819 . . . . 3.23 109.667 176.328 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 121.783 0.802 . . . . 3.82 110.054 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.25 -22.73 12.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.278 -0.874 . . . . 2.94 110.364 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.73 -5.75 32.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 1.15 111.97 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.19 -36.25 83.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.722 0.296 . . . . 1.33 110.789 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -89.51 6.08 42.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.58 0.705 . . . . 1.24 109.64 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.98 91.48 22.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.758 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.21 -27.01 45.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.229 1.953 . . . . 0.67 112.397 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -47.18 93.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.598 -0.274 . . . . 1.26 110.289 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.43 -56.85 16.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.105 -0.498 . . . . 1.29 111.329 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 9.2 ptm180 -65.22 -18.05 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.572 -0.74 . . . . 2.15 112.831 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.74 -47.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 112.285 0.476 . . . . 1.52 112.285 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.59 -25.2 56.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.29 -0.564 . . . . 1.71 110.457 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.816 -0.629 . . . . 2.56 109.818 -178.39 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.8 m170 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.941 0.401 . . . . 4.56 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.01 -16.26 7.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.58 0.705 . . . . 2.52 110.205 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.67 -0.681 . . . . 3.23 109.756 -179.19 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.489 0.661 . . . . 3.82 110.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -62.52 -62.8 1.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.525 -0.761 . . . . 2.94 111.789 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 m -72.02 -7.7 50.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.15 111.677 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.07 -31.22 68.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.165 -0.471 . . . . 1.33 110.709 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -85.32 2.87 42.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.729 0.775 . . . . 1.24 109.822 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -124.0 89.5 51.62 Favored Pre-proline 0 CA--C 1.508 -0.649 0 CA-C-N 114.983 -1.008 . . . . 0.43 109.333 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 13' ' ' VAL . 50.1 Cg_exo -56.17 -18.88 25.13 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.55 2.167 . . . . 0.67 112.803 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.39 -32.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.587 0.708 . . . . 1.26 110.305 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 t -75.7 -43.47 47.05 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.334 -0.546 . . . . 1.29 109.709 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.693 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 ptm180 -72.83 -17.48 61.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.472 0.915 . . . . 2.15 113.472 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 9' ' ' PRO . 8.2 m -82.56 -33.22 10.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.705 -0.225 . . . . 1.52 111.404 175.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.61 -33.55 16.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.475 -0.49 . . . . 1.71 111.476 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.693 ' OD1' ' HA ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.242 0.544 . . . . 2.56 111.684 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 . . . . . 0 C--O 1.232 0.174 0 N-CA-C 109.765 -0.457 . . . . 4.56 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG22 ' CG ' ' A' ' 15' ' ' ASN . 2.9 m -90.42 3.15 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.257 0.551 . . . . 2.52 110.855 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.305 -0.855 . . . . 3.23 109.404 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.312 0.577 . . . . 3.82 110.058 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.27 -46.31 2.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.8 -0.636 . . . . 2.94 110.856 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' C ' ' HB2' ' A' ' 19' ' ' CYS . 1.7 m -92.46 -7.03 48.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.122 -0.49 . . . . 1.15 111.3 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 19' ' ' CYS . 49.9 m -67.3 -25.19 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.465 -0.334 . . . . 1.33 111.467 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -90.51 14.47 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 1.24 109.454 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.563 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 14.1 m120 -130.25 94.74 29.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.107 -0.951 . . . . 0.43 109.057 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.442 ' O ' HG13 ' A' ' 13' ' ' VAL . 28.7 Cg_endo -60.11 -16.13 37.97 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.362 2.041 . . . . 0.67 112.818 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.74 -39.01 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 1.26 110.366 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 t -71.57 -35.16 70.48 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.51 -0.476 . . . . 1.29 110.367 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 14.4 ptm180 -82.17 -17.82 44.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.018 1.118 . . . . 2.15 114.018 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 9' ' ' PRO . 3.7 m -71.69 -33.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 O-C-N 121.89 -0.506 . . . . 1.52 111.045 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.67 -50.77 63.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.228 -0.589 . . . . 1.71 110.121 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 N--CA 1.434 -1.252 0 CA-C-N 115.448 -0.796 . . . . 2.56 111.653 -172.615 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 121.403 0.62 . . . . 4.56 110.468 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.33 69.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.509 -0.923 . . . . 2.52 108.509 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 2.1 p . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.036 -0.984 . . . . 3.23 111.585 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.194 0.521 . . . . 3.82 110.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.87 -55.14 4.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.802 -0.635 . . . . 2.94 110.274 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 1.6 p -68.34 -10.37 54.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 1.15 110.728 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 34.3 t -63.31 -26.9 68.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 1.33 110.697 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -85.48 7.17 23.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.443 0.639 . . . . 1.24 110.1 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 12.8 m120 -115.84 114.93 41.59 Favored Pre-proline 0 CA--C 1.513 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.43 109.78 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 -15.61 47.99 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.078 1.852 . . . . 0.67 112.99 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -83.98 -28.35 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 1.26 110.475 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 46.6 t -82.36 -44.0 16.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.702 -0.799 . . . . 1.29 110.428 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 15' ' ' ASN . 13.7 ptt180 -72.13 -17.76 61.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.949 0.722 . . . . 2.15 112.949 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.43 -40.71 42.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.505 -0.316 . . . . 1.52 110.852 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 8.5 p30 -88.06 -30.61 19.79 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.382 -0.527 . . . . 1.71 111.144 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.601 ' CG ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 122.148 0.975 . . . . 2.56 110.628 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 m80 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 111.678 0.251 . . . . 4.56 111.678 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.601 HG12 ' CG ' ' A' ' 15' ' ' ASN . 4.3 p -93.02 -30.98 4.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.667 -0.813 . . . . 2.52 108.934 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.1 -0.955 . . . . 3.23 108.694 174.067 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.651 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 5.1 m-20 . . . . . 0 C--O 1.236 0.351 0 CA-C-O 120.928 0.394 . . . . 3.82 111.346 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.16 -62.43 1.38 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.946 -0.57 . . . . 2.94 110.782 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.9 m -60.15 -25.78 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.446 . . . . 1.15 111.843 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.0 m -62.54 -28.74 70.06 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 1.33 111.116 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t -91.45 -5.34 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 1.24 110.22 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.6 m-80 -118.98 102.75 48.84 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-N 115.646 -0.706 . . . . 0.43 109.946 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.31 -18.36 37.57 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.169 1.913 . . . . 0.67 113.034 -175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 13' ' ' VAL . 9.8 p -80.6 -37.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.519 0.676 . . . . 1.26 110.666 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 13.2 t -76.46 -42.27 44.36 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.998 -0.681 . . . . 1.29 110.141 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 12.0 ptm180 -73.38 -26.23 60.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.026 0.75 . . . . 2.15 113.026 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -66.95 -40.81 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.696 0.284 . . . . 1.52 111.294 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' HG13 ' A' ' 13' ' ' VAL . 8.0 p30 -90.11 -21.9 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 1.71 110.888 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.696 0.76 . . . . 2.56 111.141 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.9 m80 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.204 0.526 . . . . 4.56 111.442 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.56 -42.55 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.009 -0.738 . . . . 2.52 109.009 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 3' ' ' ASP . 49.8 t . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.657 -1.156 . . . . 3.23 108.184 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 121.084 0.468 . . . . 3.82 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.59 11.7 38.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 2.94 111.205 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -68.61 -6.49 26.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.49 -177.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.4 m -60.41 -26.02 66.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 1.33 111.099 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -87.03 15.93 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.856 0.836 . . . . 1.24 109.287 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -129.77 97.88 23.21 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 114.728 -1.123 . . . . 0.43 108.121 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.492 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -54.3 -25.61 39.6 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.197 1.932 . . . . 0.67 112.679 -174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -73.76 -35.18 42.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.975 0.417 . . . . 1.26 110.396 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -67.98 -40.23 83.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 1.29 110.428 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 11.9 ptm180 -82.49 -34.14 28.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.498 0.925 . . . . 2.15 113.498 -171.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.7 m -58.82 -48.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 111.749 0.277 . . . . 1.52 111.749 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' N ' HG23 ' A' ' 13' ' ' VAL . 20.1 p30 -91.81 -3.05 56.59 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.716 -0.394 . . . . 1.71 111.961 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 2.56 110.529 179.226 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 m80 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 112.011 0.374 . . . . 4.56 112.011 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 p -58.98 -32.26 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.921 0.391 . . . . 2.52 111.09 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 24.5 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.87 -0.586 . . . . 3.23 110.039 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.53 0.681 . . . . 3.82 110.621 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.04 -23.93 60.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.754 -1.112 . . . . 2.94 110.751 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -64.37 -14.75 58.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.468 0.544 . . . . 1.15 112.468 -172.061 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.55 -37.82 80.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 1.33 110.597 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.8 t -82.71 4.95 22.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.649 0.737 . . . . 1.24 109.8 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.29 107.64 47.01 Favored Pre-proline 0 CA--C 1.509 -0.614 0 CA-C-N 115.12 -0.945 . . . . 0.43 109.482 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.58 -20.5 70.92 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.622 1.548 . . . . 0.67 111.935 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -73.83 -31.29 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.396 0.617 . . . . 1.26 109.639 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 73.9 m -76.19 -56.28 4.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.82 -0.627 . . . . 1.29 110.595 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -63.6 -19.22 64.67 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.907 0.706 . . . . 2.15 112.907 -173.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -89.78 -35.51 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 112.336 0.495 . . . . 1.52 112.336 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 2.4 p30 -80.13 -31.13 39.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.131 -0.628 . . . . 1.71 110.063 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 109.328 -0.619 . . . . 2.56 109.328 176.258 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.305 0.574 . . . . 4.56 110.624 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.51 -32.31 49.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.805 -0.634 . . . . 2.52 110.169 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.707 -0.663 . . . . 3.23 109.464 175.847 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.236 0.541 . . . . 3.82 111.789 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.8 -20.34 61.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.629 -0.714 . . . . 2.94 110.847 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -61.55 -8.2 4.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.153 -0.476 . . . . 1.15 112.084 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.1 -33.32 73.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.995 0.426 . . . . 1.33 110.241 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -85.32 1.1 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 1.24 109.719 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -119.52 90.69 43.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.676 -1.147 . . . . 0.43 108.771 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.573 ' O ' HG13 ' A' ' 13' ' ' VAL . 18.5 Cg_endo -56.73 -22.16 43.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.134 1.89 . . . . 0.67 112.495 -174.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.67 -31.85 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.522 0.677 . . . . 1.26 110.077 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HA ' HD21 ' A' ' 14' ' ' ASN . 38.3 t -76.72 -32.79 58.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.099 -0.5 . . . . 1.29 110.286 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -83.12 -21.56 33.59 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.515 0.932 . . . . 2.15 113.515 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 9' ' ' PRO . 16.3 m -72.33 -36.14 54.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 111.76 0.282 . . . . 1.52 111.76 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 11' ' ' CYS . 9.6 p30 -87.27 -10.05 53.4 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.594 -0.442 . . . . 1.71 110.575 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 115.811 -0.631 . . . . 2.56 109.329 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.044 0.45 . . . . 4.56 110.562 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.734 -0.469 . . . . 2.52 109.734 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.253 1.255 0 CA-C-N 115.605 -0.725 . . . . 3.23 109.152 178.231 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 121.206 0.527 . . . . 3.82 111.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.0 -14.55 60.63 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.495 -0.775 . . . . 2.94 110.065 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 1.5 m -63.45 -7.6 7.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.016 -0.538 . . . . 1.15 112.408 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.3 m -65.09 -37.2 86.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.484 -0.562 . . . . 1.33 109.484 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -87.58 7.23 30.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.635 -0.711 . . . . 1.24 109.98 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 17.6 m-80 -120.7 93.24 48.5 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-N 115.186 -0.915 . . . . 0.43 108.925 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.85 -22.78 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.047 1.831 . . . . 0.67 112.511 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 11' ' ' CYS . 14.0 p -64.1 -46.89 92.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 1.26 110.216 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.42 ' N ' HG13 ' A' ' 10' ' ' VAL . 81.0 m -61.72 -55.39 30.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.755 . . . . 1.29 111.154 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -70.38 -16.71 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.158 0.799 . . . . 2.15 113.158 -171.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.09 -40.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.145 0.424 . . . . 1.52 112.145 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.32 -25.11 42.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.915 -0.714 . . . . 1.71 109.755 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 108.988 -0.745 . . . . 2.56 108.988 -177.96 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 108.324 -0.991 . . . . 4.56 108.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.55 -29.14 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.274 -0.875 . . . . 2.52 110.421 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-N 116.092 -0.503 . . . . 3.23 110.209 175.388 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.0 t70 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 108.859 -0.793 . . . . 3.82 108.859 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.87 -16.38 63.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.363 -0.38 . . . . 2.94 111.607 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.681 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -66.82 -10.07 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.15 110.896 177.267 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.6 t -63.79 -32.41 73.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.124 -0.489 . . . . 1.33 110.133 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 t -88.77 17.15 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.538 0.685 . . . . 1.24 110.105 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 27.2 m-80 -132.93 104.68 12.71 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-N 115.579 -0.737 . . . . 0.43 109.974 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.559 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -56.9 -24.44 56.62 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.895 1.73 . . . . 0.67 112.196 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.44 -33.53 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.828 0.823 . . . . 1.26 110.301 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.8 m -73.83 -43.38 58.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.532 -0.758 . . . . 1.29 109.946 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 28.9 mtp180 -68.71 -38.95 80.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.234 -0.894 . . . . 2.15 112.898 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' PRO . 15.8 m -63.5 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.806 -0.634 . . . . 1.52 112.205 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -87.13 -34.49 19.07 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.654 -0.418 . . . . 1.71 111.281 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 121.945 0.879 . . . . 2.56 110.554 178.561 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 CA--C 1.523 -0.058 0 CA-C-O 121.096 0.474 . . . . 4.56 111.399 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.75 -28.04 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.163 0.506 . . . . 2.52 110.318 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.732 . . . . 3.23 109.672 176.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.814 -0.439 . . . . 3.82 109.814 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.66 -20.29 33.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.116 -0.493 . . . . 2.94 110.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -17.74 62.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.15 110.808 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 46.6 t -59.72 -36.36 76.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.86 -0.609 . . . . 1.33 111.323 174.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -84.16 -6.82 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.433 0.635 . . . . 1.24 109.797 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 24.8 m-80 -99.63 111.61 61.94 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.43 110.125 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.88 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.716 1.611 . . . . 0.67 112.442 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.91 -42.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.494 0.664 . . . . 1.26 110.035 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -69.44 -52.6 25.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 1.29 111.374 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 8.7 ptm180 -64.94 -21.02 66.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.942 0.719 . . . . 2.15 112.942 -175.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 t -88.65 -38.52 11.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.035 0.445 . . . . 1.52 111.943 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -81.33 -21.2 39.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.431 0.634 . . . . 1.71 110.266 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 109.205 -0.665 . . . . 2.56 109.205 -177.695 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.794 0.807 . . . . 4.56 108.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.57 -26.16 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.372 -0.831 . . . . 2.52 110.093 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.515 -0.755 . . . . 3.23 109.877 -179.456 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 109.368 -0.605 . . . . 3.82 109.368 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.73 -36.83 59.83 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.721 0.296 . . . . 2.94 111.204 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 1.1 p -69.1 -8.41 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.766 0.284 . . . . 1.15 111.766 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.16 -28.59 69.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.733 0.301 . . . . 1.33 111.283 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.5 p -79.93 4.19 17.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.873 0.844 . . . . 1.24 109.729 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 14.3 m120 -116.66 106.23 48.6 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.597 -1.183 . . . . 0.43 109.392 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.6 Cg_exo -54.62 -24.18 35.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.198 1.932 . . . . 0.67 112.686 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.82 -35.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.26 110.794 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.85 -37.56 67.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 1.29 110.326 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.797 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.1 ptm180 -82.2 -18.15 43.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.728 1.01 . . . . 2.15 113.728 -172.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.8 m -78.22 -34.14 18.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 111.519 0.192 . . . . 1.52 111.519 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.24 -36.09 14.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.536 -0.465 . . . . 1.71 111.583 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.797 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 120.947 0.403 . . . . 2.56 110.183 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 111.94 0.348 . . . . 4.56 111.94 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.78 -15.68 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.799 0.809 . . . . 2.52 108.836 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 12' ' ' ARG . 93.0 m . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.791 -1.095 . . . . 3.23 109.58 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.5 t70 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 108.713 -0.847 . . . . 3.82 108.713 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.8 -26.94 60.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 2.94 111.205 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 m -73.62 -8.17 54.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.118 0.414 . . . . 1.15 112.118 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 3' ' ' ASP . 63.5 m -64.97 -37.01 86.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.869 0.366 . . . . 1.33 110.633 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.6 m -89.06 21.04 3.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.844 0.83 . . . . 1.24 109.75 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -127.31 98.48 29.39 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-N 114.891 -1.05 . . . . 0.43 109.13 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.22 -13.74 37.56 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.745 1.63 . . . . 0.67 111.793 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' VAL . 84.1 t -78.81 -32.49 15.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.301 0.572 . . . . 1.26 110.184 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.6 m -72.17 -51.06 23.0 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.898 0.38 . . . . 1.29 110.196 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.703 ' HB3' ' OXT' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.89 -17.67 60.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.621 0.971 . . . . 2.15 113.621 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.1 p -71.09 -38.61 72.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 121.12 -0.232 . . . . 1.52 110.612 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.24 -28.2 14.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.293 0.479 . . . . 1.71 112.293 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 30.0 p30 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 122.301 1.048 . . . . 2.56 111.045 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.0 p80 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.821 0.343 . . . . 4.56 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.63 -73.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.41 . . . . 2.52 110.702 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.703 ' OXT' ' HB3' ' A' ' 12' ' ' ARG . 50.8 t . . . . . 0 C--O 1.252 1.233 0 N-CA-C 108.864 -0.791 . . . . 3.23 108.864 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 19.2 m-20 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.889 0.376 . . . . 3.82 110.979 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -67.22 -56.32 10.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 2.94 110.491 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.86 -6.92 23.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 1.15 111.75 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 48.6 t -66.58 -18.89 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.432 0.634 . . . . 1.33 110.548 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -101.96 6.52 41.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.696 -0.684 . . . . 1.24 109.759 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 12.9 m120 -117.15 111.1 40.68 Favored Pre-proline 0 CA--C 1.507 -0.698 0 CA-C-N 115.318 -0.856 . . . . 0.43 109.14 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.1 Cg_endo -62.61 -21.54 73.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.782 1.655 . . . . 0.67 112.433 -172.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.8 t -80.56 -41.38 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.339 -0.391 . . . . 1.26 110.578 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.11 -39.26 81.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.37 0.605 . . . . 1.29 110.665 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 52.3 mtp180 -73.6 -35.18 65.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.957 -1.02 . . . . 2.15 112.112 -172.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 9' ' ' PRO . 20.2 m -84.87 -22.55 7.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.221 -0.899 . . . . 1.52 111.621 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.95 -31.75 20.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.342 0.591 . . . . 1.71 110.119 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.549 -0.751 . . . . 2.56 109.028 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.0 m80 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.281 -0.637 . . . . 4.56 109.281 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.73 -33.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 2.52 110.968 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.703 -0.665 . . . . 3.23 109.902 -177.924 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 6.78 109.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 6.7 tpm_? -172.85 47.85 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.6 -1.182 . . . . 7.47 108.636 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.98 67.41 7.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.751 . . . . 3.82 110.778 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 2.94 110.465 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -70.49 -9.01 55.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.693 -0.685 . . . . 1.15 111.798 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 t -64.65 -31.61 72.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.769 0.318 . . . . 1.33 110.509 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 t -87.0 20.54 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.601 0.715 . . . . 1.24 109.67 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 15.5 m120 -132.47 111.36 13.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.178 -0.919 . . . . 0.43 109.492 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.43 -13.65 40.91 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.143 1.896 . . . . 0.67 112.487 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 13' ' ' VAL . 23.8 t -84.23 -31.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 1.26 110.315 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 85.5 m -76.33 -50.28 14.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.652 -0.419 . . . . 1.29 110.243 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 19.9 ptt180 -71.15 -17.01 62.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.95 0.722 . . . . 2.15 112.95 -173.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -73.66 -38.82 52.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 110.459 -0.2 . . . . 1.52 110.459 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -87.83 -34.7 18.16 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.346 -0.542 . . . . 1.71 111.514 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' A' ' 18' ' ' VAL . 7.2 p30 -81.0 141.02 34.83 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.971 0.891 . . . . 2.56 110.129 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -163.89 45.22 0.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 4.56 111.294 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.467 ' HB ' ' ND2' ' A' ' 15' ' ' ASN . 44.0 t -83.87 71.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.721 0.772 . . . . 2.52 110.104 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.249 1.048 0 CA-C-N 114.553 -1.203 . . . . 3.23 109.371 175.034 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.767 0.317 . . . . 6.78 110.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -138.95 127.91 23.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 110.009 -0.367 . . . . 7.47 110.009 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.58 77.2 3.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.082 0.468 . . . . 3.82 110.547 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.7 -23.49 59.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.315 0.579 . . . . 2.94 110.447 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.9 p -70.74 -5.32 29.05 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.618 -0.719 . . . . 1.15 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.54 -27.3 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.748 0.419 . . . . 1.33 111.154 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -89.6 16.97 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.606 0.717 . . . . 1.24 109.825 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -130.03 102.15 17.67 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.731 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.8 Cg_exo -56.21 -22.13 39.03 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.028 1.819 . . . . 0.67 112.305 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.57 -29.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.684 0.754 . . . . 1.26 110.394 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -76.68 -43.65 36.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.545 -0.752 . . . . 1.29 110.541 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -79.64 -16.21 56.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.135 0.791 . . . . 2.15 113.135 -171.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' PRO . 11.0 m -75.31 -43.61 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.601 0.239 . . . . 1.52 111.348 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 16' ' ' HYP . 4.9 p30 -80.81 -37.34 30.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.989 0.423 . . . . 1.71 109.961 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' HA ' HD23 ' A' ' 16' ' ' HYP . 0.1 OUTLIER -94.61 103.62 15.56 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.681 -0.859 . . . . 2.56 108.681 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 60.22 41.13 17.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.601 -1.182 . . . . 4.56 111.913 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.67 -10.87 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.677 0.751 . . . . 2.52 109.395 169.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.468 -1.242 . . . . 3.23 108.852 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.824 0.345 . . . . 6.78 110.687 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 3.4 mmp_? -83.67 140.35 32.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.484 . . . . 7.47 109.91 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.26 99.92 10.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 3.82 111.097 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -60.52 -12.66 10.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.6 -0.727 . . . . 2.94 110.514 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 m -58.92 -11.73 3.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.653 -0.703 . . . . 1.15 112.757 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.28 -40.84 98.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.725 0.298 . . . . 1.33 111.418 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 p -91.87 -8.25 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.229 0.538 . . . . 1.24 110.713 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 23.9 m-80 -97.03 100.63 7.88 Favored Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.567 -0.742 . . . . 0.43 109.123 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 19.2 Cg_endo -56.51 -23.27 46.95 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.895 1.73 . . . . 0.67 112.552 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 -38.06 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.477 0.656 . . . . 1.26 110.378 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.8 m -63.58 -47.67 80.57 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.312 -0.858 . . . . 1.29 110.858 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG3' ' HA ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -71.63 -25.27 62.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 2.15 111.971 -172.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 9' ' ' PRO . 18.5 m -88.78 -25.7 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 112.184 0.439 . . . . 1.52 112.184 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -85.14 -36.43 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.532 0.682 . . . . 1.71 109.864 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HG12 ' A' ' 18' ' ' VAL . 2.5 t-20 -140.16 88.31 2.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.07 -0.968 . . . . 2.56 109.148 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.411 ' CE1' HD22 ' A' ' 15' ' ' ASN . 7.7 p-80 -165.67 27.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.606 -0.725 . . . . 4.56 110.621 172.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 15' ' ' ASN . 7.2 p -114.08 76.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.272 1.034 . . . . 2.52 110.585 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.157 -0.929 . . . . 3.23 110.095 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.778 -0.452 . . . . 6.78 109.778 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -128.3 140.35 51.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.487 -0.561 . . . . 7.47 109.487 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -78.67 84.05 4.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 3.82 109.938 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.29 9.76 31.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.606 -0.725 . . . . 2.94 111.554 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.5 m -61.35 -12.61 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.775 0.322 . . . . 1.15 111.755 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.51 -32.76 74.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.327 -0.397 . . . . 1.33 110.401 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -89.18 11.68 18.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.364 0.602 . . . . 1.24 110.277 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.3 m-80 -135.04 97.29 13.72 Favored Pre-proline 0 CA--C 1.508 -0.655 0 CA-C-N 115.574 -0.739 . . . . 0.43 109.609 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.81 -18.74 22.52 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.407 2.072 . . . . 0.67 113.011 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.75 -42.47 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 1.26 110.201 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.83 -35.52 38.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.738 -0.665 . . . . 1.29 111.576 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.0 ptm180 -70.16 -26.37 63.89 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.089 -0.644 . . . . 2.15 111.469 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 -58.92 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.704 -0.68 . . . . 1.52 112.559 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.15 -44.32 89.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.946 0.403 . . . . 1.71 110.606 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.452 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -88.51 157.01 18.77 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.933 -0.766 . . . . 2.56 108.933 172.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 50.9 m80 75.29 -47.9 0.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.171 -0.922 . . . . 4.56 112.355 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 15' ' ' ASN . 55.8 t 70.43 -52.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.05 0.54 . . . . 2.52 111.224 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 119.003 -0.523 . . . . 3.23 110.339 176.745 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.556 ' HB ' ' OD1' ' A' ' 3' ' ' ASP . 33.1 pt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.749 0.309 . . . . 6.78 110.556 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 2' ' ' ARG . 33.4 mtm180 -102.52 12.04 37.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.465 0.65 . . . . 7.47 110.533 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.556 ' OD1' ' HB ' ' A' ' 1' ' ' ILE . 5.3 p-10 -109.72 41.02 1.77 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.121 -0.945 . . . . 3.82 111.09 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.02 -46.96 72.89 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.131 -0.941 . . . . 2.94 110.249 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.0 m -65.03 -16.54 63.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.14 -0.482 . . . . 1.15 112.068 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 14.4 m -59.84 -26.37 65.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.806 0.299 . . . . 1.33 111.806 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.8 m -93.39 9.52 36.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.551 0.691 . . . . 1.24 110.229 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 14.1 m120 -127.94 92.54 41.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.339 -0.846 . . . . 0.43 109.286 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.35 -24.01 25.96 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.334 2.022 . . . . 0.67 112.946 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.8 p -79.88 -33.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.85 0.833 . . . . 1.26 110.172 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t -73.96 -39.67 63.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.301 -0.863 . . . . 1.29 110.11 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.7 ptt180 -83.47 -27.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.752 1.019 . . . . 2.15 113.752 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 10' ' ' VAL . 11.3 p -59.68 -37.08 69.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 1.52 110.435 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -76.28 -42.79 44.3 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.545 0.688 . . . . 1.71 110.041 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -136.09 85.11 2.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.041 -0.982 . . . . 2.56 109.805 -165.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -122.41 35.22 4.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.391 0.615 . . . . 4.56 109.591 172.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.76 -29.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.378 -0.828 . . . . 2.52 111.666 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.636 -0.697 . . . . 3.23 110.141 -179.149 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.8 tt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.747 0.308 . . . . 6.78 110.369 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -80.75 88.72 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.096 0.475 . . . . 7.47 110.081 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -13.76 61.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.126 0.965 . . . . 3.82 110.385 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.2 -29.7 70.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.111 -1.404 . . . . 2.94 110.987 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -17.26 64.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.504 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -61.04 -35.42 76.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.703 0.287 . . . . 1.33 111.394 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 t -83.44 -6.4 59.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.669 . . . . 1.24 109.743 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -99.67 107.37 45.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.083 -0.962 . . . . 0.43 109.62 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 25.7 Cg_endo -60.55 -18.28 53.54 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.753 1.636 . . . . 0.67 112.7 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.4 p -75.58 -31.63 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 1.26 110.177 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 46.4 t -72.77 -48.85 34.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.606 -0.725 . . . . 1.29 110.151 177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HA ' HD22 ' A' ' 15' ' ' ASN . 16.7 ptt180 -76.91 -17.79 58.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.282 0.845 . . . . 2.15 113.282 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 10' ' ' VAL . 12.1 p -75.11 -32.61 26.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.519 0.2 . . . . 1.52 110.933 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -102.95 -39.2 7.03 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.545 -0.462 . . . . 1.71 111.84 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.569 HD22 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -70.19 144.5 51.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.768 0.794 . . . . 2.56 111.182 -177.041 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -147.29 48.5 1.12 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 4.56 110.776 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.9 -41.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.38 -0.819 . . . . 3.23 109.667 176.328 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.2 pt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.934 0.397 . . . . 6.78 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -157.27 -175.6 5.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.138 -0.483 . . . . 7.47 109.844 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 58.31 32.8 22.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.783 0.802 . . . . 3.82 110.054 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.25 -22.73 12.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.278 -0.874 . . . . 2.94 110.364 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.73 -5.75 32.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 1.15 111.97 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.19 -36.25 83.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.722 0.296 . . . . 1.33 110.789 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -89.51 6.08 42.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.58 0.705 . . . . 1.24 109.64 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.98 91.48 22.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.758 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.21 -27.01 45.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.229 1.953 . . . . 0.67 112.397 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -47.18 93.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.598 -0.274 . . . . 1.26 110.289 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.43 -56.85 16.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.105 -0.498 . . . . 1.29 111.329 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 9.2 ptm180 -65.22 -18.05 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.572 -0.74 . . . . 2.15 112.831 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.74 -47.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 112.285 0.476 . . . . 1.52 112.285 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.59 -25.2 56.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.29 -0.564 . . . . 1.71 110.457 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -134.98 89.48 2.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.816 -0.629 . . . . 2.56 109.818 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -144.41 18.32 1.7 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.135 -0.484 . . . . 4.56 110.468 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.01 -16.26 7.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.58 0.705 . . . . 2.52 110.205 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.67 -0.681 . . . . 3.23 109.756 -179.19 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.284 -0.265 . . . . 6.78 110.284 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -79.0 127.11 31.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 7.47 110.262 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -92.94 15.21 15.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.489 0.661 . . . . 3.82 110.533 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -62.52 -62.8 1.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.525 -0.761 . . . . 2.94 111.789 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 m -72.02 -7.7 50.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.15 111.677 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.07 -31.22 68.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.165 -0.471 . . . . 1.33 110.709 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -85.32 2.87 42.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.729 0.775 . . . . 1.24 109.822 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -124.0 89.5 51.62 Favored Pre-proline 0 CA--C 1.508 -0.649 0 CA-C-N 114.983 -1.008 . . . . 0.43 109.333 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 13' ' ' VAL . 50.1 Cg_exo -56.17 -18.88 25.13 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.55 2.167 . . . . 0.67 112.803 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.39 -32.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.587 0.708 . . . . 1.26 110.305 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 t -75.7 -43.47 47.05 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.334 -0.546 . . . . 1.29 109.709 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.693 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 ptm180 -72.83 -17.48 61.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.472 0.915 . . . . 2.15 113.472 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 9' ' ' PRO . 8.2 m -82.56 -33.22 10.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.705 -0.225 . . . . 1.52 111.404 175.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.61 -33.55 16.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.475 -0.49 . . . . 1.71 111.476 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.693 ' OD1' ' HA ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -65.08 154.61 37.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.242 0.544 . . . . 2.56 111.684 -177.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -148.36 46.82 1.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.103 -0.499 . . . . 4.56 109.765 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG22 ' CG ' ' A' ' 15' ' ' ASN . 2.9 m -90.42 3.15 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.257 0.551 . . . . 2.52 110.855 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.305 -0.855 . . . . 3.23 109.404 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 35.0 pt . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.043 0.449 . . . . 6.78 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -113.24 68.26 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.053 -0.521 . . . . 7.47 110.204 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.91 79.56 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.763 -0.653 . . . . 3.82 110.058 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.27 -46.31 2.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.8 -0.636 . . . . 2.94 110.856 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' C ' ' HB2' ' A' ' 19' ' ' CYS . 1.7 m -92.46 -7.03 48.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.122 -0.49 . . . . 1.15 111.3 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 19' ' ' CYS . 49.9 m -67.3 -25.19 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.465 -0.334 . . . . 1.33 111.467 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -90.51 14.47 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 1.24 109.454 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.563 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 14.1 m120 -130.25 94.74 29.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.107 -0.951 . . . . 0.43 109.057 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.442 ' O ' HG13 ' A' ' 13' ' ' VAL . 28.7 Cg_endo -60.11 -16.13 37.97 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.362 2.041 . . . . 0.67 112.818 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.74 -39.01 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 1.26 110.366 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 t -71.57 -35.16 70.48 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.51 -0.476 . . . . 1.29 110.367 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 14.4 ptm180 -82.17 -17.82 44.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.018 1.118 . . . . 2.15 114.018 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 9' ' ' PRO . 3.7 m -71.69 -33.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 O-C-N 121.89 -0.506 . . . . 1.52 111.045 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.67 -50.77 63.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.228 -0.589 . . . . 1.71 110.121 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' HA ' HD23 ' A' ' 16' ' ' HYP . 19.6 p30 -81.57 158.41 24.41 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.448 -0.796 . . . . 2.56 111.653 -172.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 72.23 12.59 5.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.559 -0.746 . . . . 4.56 110.468 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.33 69.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.509 -0.923 . . . . 2.52 108.509 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 2.1 p . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.036 -0.984 . . . . 3.23 111.585 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.892 -0.41 . . . . 6.78 109.892 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -84.43 115.3 22.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.643 -0.502 . . . . 7.47 109.643 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -82.23 57.93 3.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.194 0.521 . . . . 3.82 110.208 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.87 -55.14 4.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.802 -0.635 . . . . 2.94 110.274 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 1.6 p -68.34 -10.37 54.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 1.15 110.728 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 34.3 t -63.31 -26.9 68.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 1.33 110.697 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -85.48 7.17 23.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.443 0.639 . . . . 1.24 110.1 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 12.8 m120 -115.84 114.93 41.59 Favored Pre-proline 0 CA--C 1.513 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.43 109.78 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 -15.61 47.99 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.078 1.852 . . . . 0.67 112.99 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -83.98 -28.35 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 1.26 110.475 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 46.6 t -82.36 -44.0 16.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.702 -0.799 . . . . 1.29 110.428 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 15' ' ' ASN . 13.7 ptt180 -72.13 -17.76 61.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.949 0.722 . . . . 2.15 112.949 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.43 -40.71 42.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.505 -0.316 . . . . 1.52 110.852 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 8.5 p30 -88.06 -30.61 19.79 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.382 -0.527 . . . . 1.71 111.144 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.601 ' CG ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -67.99 132.71 47.8 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.148 0.975 . . . . 2.56 110.628 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.478 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -154.14 49.38 0.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.037 -0.529 . . . . 4.56 111.678 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.601 HG12 ' CG ' ' A' ' 15' ' ' ASN . 4.3 p -93.02 -30.98 4.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.667 -0.813 . . . . 2.52 108.934 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.1 -0.955 . . . . 3.23 108.694 174.067 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.674 0.75 . . . . 6.78 110.895 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.582 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 5.1 mmp_? -136.45 41.93 2.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.202 -0.908 . . . . 7.47 108.911 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.651 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 5.1 m-20 -94.14 50.18 1.37 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.132 -0.94 . . . . 3.82 111.346 -169.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.16 -62.43 1.38 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.946 -0.57 . . . . 2.94 110.782 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.9 m -60.15 -25.78 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.446 . . . . 1.15 111.843 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.0 m -62.54 -28.74 70.06 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 1.33 111.116 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t -91.45 -5.34 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 1.24 110.22 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.6 m-80 -118.98 102.75 48.84 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-N 115.646 -0.706 . . . . 0.43 109.946 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.31 -18.36 37.57 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.169 1.913 . . . . 0.67 113.034 -175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 13' ' ' VAL . 9.8 p -80.6 -37.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.519 0.676 . . . . 1.26 110.666 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 13.2 t -76.46 -42.27 44.36 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.998 -0.681 . . . . 1.29 110.141 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 12.0 ptm180 -73.38 -26.23 60.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.026 0.75 . . . . 2.15 113.026 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -66.95 -40.81 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.696 0.284 . . . . 1.52 111.294 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' HG13 ' A' ' 13' ' ' VAL . 8.0 p30 -90.11 -21.9 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 1.71 110.888 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -69.64 138.76 53.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.696 0.76 . . . . 2.56 111.141 -177.012 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.457 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.9 m80 60.86 42.9 12.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 4.56 111.442 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.56 -42.55 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.009 -0.738 . . . . 2.52 109.009 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 3' ' ' ASP . 49.8 t . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.657 -1.156 . . . . 3.23 108.184 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.993 -0.373 . . . . 6.78 109.993 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -128.67 30.3 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 7.47 110.877 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -93.15 98.7 11.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 3.82 110.211 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.59 11.7 38.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 2.94 111.205 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -68.61 -6.49 26.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.49 -177.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.4 m -60.41 -26.02 66.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 1.33 111.099 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -87.03 15.93 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.856 0.836 . . . . 1.24 109.287 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -129.77 97.88 23.21 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 114.728 -1.123 . . . . 0.43 108.121 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -54.3 -25.61 39.6 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.197 1.932 . . . . 0.67 112.679 -174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -73.76 -35.18 42.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.975 0.417 . . . . 1.26 110.396 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -67.98 -40.23 83.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 1.29 110.428 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 11.9 ptm180 -82.49 -34.14 28.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.498 0.925 . . . . 2.15 113.498 -171.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.7 m -58.82 -48.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 111.749 0.277 . . . . 1.52 111.749 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' N ' HG23 ' A' ' 13' ' ' VAL . 20.1 p30 -91.81 -3.05 56.59 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.716 -0.394 . . . . 1.71 111.961 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -159.39 92.04 1.04 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 2.56 110.529 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -118.15 -32.28 4.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.011 0.374 . . . . 4.56 112.011 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 p -58.98 -32.26 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.921 0.391 . . . . 2.52 111.09 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 24.5 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.87 -0.586 . . . . 3.23 110.039 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.648 0.261 . . . . 6.78 110.766 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -160.18 47.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 7.47 109.367 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.51 -3.15 32.46 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.595 -0.729 . . . . 3.82 110.621 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.04 -23.93 60.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.754 -1.112 . . . . 2.94 110.751 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -64.37 -14.75 58.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.468 0.544 . . . . 1.15 112.468 -172.061 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.55 -37.82 80.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 1.33 110.597 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.8 t -82.71 4.95 22.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.649 0.737 . . . . 1.24 109.8 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.29 107.64 47.01 Favored Pre-proline 0 CA--C 1.509 -0.614 0 CA-C-N 115.12 -0.945 . . . . 0.43 109.482 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.58 -20.5 70.92 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.622 1.548 . . . . 0.67 111.935 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -73.83 -31.29 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.396 0.617 . . . . 1.26 109.639 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 73.9 m -76.19 -56.28 4.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.82 -0.627 . . . . 1.29 110.595 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -63.6 -19.22 64.67 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.907 0.706 . . . . 2.15 112.907 -173.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -89.78 -35.51 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 112.336 0.495 . . . . 1.52 112.336 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 2.4 p30 -80.13 -31.13 39.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.131 -0.628 . . . . 1.71 110.063 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -84.41 160.27 20.65 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 109.328 -0.619 . . . . 2.56 109.328 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 58.73 57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.726 . . . . 4.56 110.624 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.51 -32.31 49.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.805 -0.634 . . . . 2.52 110.169 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.707 -0.663 . . . . 3.23 109.464 175.847 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.059 -0.348 . . . . 6.78 110.059 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -71.7 129.77 39.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.67 -0.493 . . . . 7.47 109.67 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.29 40.73 1.26 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.236 0.541 . . . . 3.82 111.789 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.8 -20.34 61.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.629 -0.714 . . . . 2.94 110.847 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -61.55 -8.2 4.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.153 -0.476 . . . . 1.15 112.084 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.1 -33.32 73.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.995 0.426 . . . . 1.33 110.241 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -85.32 1.1 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 1.24 109.719 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -119.52 90.69 43.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.676 -1.147 . . . . 0.43 108.771 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.573 ' O ' HG13 ' A' ' 13' ' ' VAL . 18.5 Cg_endo -56.73 -22.16 43.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.134 1.89 . . . . 0.67 112.495 -174.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.67 -31.85 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.522 0.677 . . . . 1.26 110.077 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HA ' HD21 ' A' ' 14' ' ' ASN . 38.3 t -76.72 -32.79 58.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.099 -0.5 . . . . 1.29 110.286 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -83.12 -21.56 33.59 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.515 0.932 . . . . 2.15 113.515 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 9' ' ' PRO . 16.3 m -72.33 -36.14 54.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 111.76 0.282 . . . . 1.52 111.76 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 11' ' ' CYS . 9.6 p30 -87.27 -10.05 53.4 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.594 -0.442 . . . . 1.71 110.575 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -136.3 79.97 1.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.811 -0.631 . . . . 2.56 109.329 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -147.24 13.36 1.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.044 0.45 . . . . 4.56 110.562 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.734 -0.469 . . . . 2.52 109.734 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.253 1.255 0 CA-C-N 115.605 -0.725 . . . . 3.23 109.152 178.231 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.3 pt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.298 -0.26 . . . . 6.78 110.298 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -80.24 97.53 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.011 0.434 . . . . 7.47 110.064 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.26 0.47 14.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.206 0.527 . . . . 3.82 111.508 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.0 -14.55 60.63 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.495 -0.775 . . . . 2.94 110.065 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 1.5 m -63.45 -7.6 7.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.016 -0.538 . . . . 1.15 112.408 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.3 m -65.09 -37.2 86.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.484 -0.562 . . . . 1.33 109.484 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -87.58 7.23 30.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.635 -0.711 . . . . 1.24 109.98 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 17.6 m-80 -120.7 93.24 48.5 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-N 115.186 -0.915 . . . . 0.43 108.925 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.85 -22.78 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.047 1.831 . . . . 0.67 112.511 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 11' ' ' CYS . 14.0 p -64.1 -46.89 92.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 1.26 110.216 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.42 ' N ' HG13 ' A' ' 10' ' ' VAL . 81.0 m -61.72 -55.39 30.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.755 . . . . 1.29 111.154 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -70.38 -16.71 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.158 0.799 . . . . 2.15 113.158 -171.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.09 -40.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.145 0.424 . . . . 1.52 112.145 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.32 -25.11 42.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.915 -0.714 . . . . 1.71 109.755 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -140.68 90.41 2.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.988 -0.745 . . . . 2.56 108.988 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -166.86 28.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.911 -1.04 . . . . 4.56 108.324 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.55 -29.14 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.274 -0.875 . . . . 2.52 110.421 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-N 116.092 -0.503 . . . . 3.23 110.209 175.388 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 110.426 -0.212 . . . . 6.78 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 64.94 173.77 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.813 0.816 . . . . 7.47 112.367 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.0 t70 -148.92 126.05 11.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.12 -0.945 . . . . 3.82 108.859 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.87 -16.38 63.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.363 -0.38 . . . . 2.94 111.607 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.681 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -66.82 -10.07 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.15 110.896 177.267 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.6 t -63.79 -32.41 73.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.124 -0.489 . . . . 1.33 110.133 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 t -88.77 17.15 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.538 0.685 . . . . 1.24 110.105 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 27.2 m-80 -132.93 104.68 12.71 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-N 115.579 -0.737 . . . . 0.43 109.974 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -56.9 -24.44 56.62 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.895 1.73 . . . . 0.67 112.196 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.44 -33.53 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.828 0.823 . . . . 1.26 110.301 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.8 m -73.83 -43.38 58.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.532 -0.758 . . . . 1.29 109.946 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 28.9 mtp180 -68.71 -38.95 80.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.234 -0.894 . . . . 2.15 112.898 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' PRO . 15.8 m -63.5 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.806 -0.634 . . . . 1.52 112.205 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -87.13 -34.49 19.07 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.654 -0.418 . . . . 1.71 111.281 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HA ' HD23 ' A' ' 16' ' ' HYP . 4.1 m120 -88.0 141.59 28.45 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.945 0.879 . . . . 2.56 110.554 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.422 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -159.76 55.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 4.56 111.399 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.75 -28.04 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.163 0.506 . . . . 2.52 110.318 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.732 . . . . 3.23 109.672 176.991 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 19' ' ' CYS . 5.2 mp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.703 -0.48 . . . . 6.78 109.703 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -82.59 62.11 6.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.197 0.522 . . . . 7.47 110.73 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -149.04 123.79 9.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.626 -0.715 . . . . 3.82 109.814 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.66 -20.29 33.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.116 -0.493 . . . . 2.94 110.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -17.74 62.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.15 110.808 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 46.6 t -59.72 -36.36 76.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.86 -0.609 . . . . 1.33 111.323 174.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -84.16 -6.82 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.433 0.635 . . . . 1.24 109.797 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 24.8 m-80 -99.63 111.61 61.94 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.43 110.125 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.88 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.716 1.611 . . . . 0.67 112.442 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.91 -42.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.494 0.664 . . . . 1.26 110.035 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -69.44 -52.6 25.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 1.29 111.374 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 8.7 ptm180 -64.94 -21.02 66.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.942 0.719 . . . . 2.15 112.942 -175.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 t -88.65 -38.52 11.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.035 0.445 . . . . 1.52 111.943 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -81.33 -21.2 39.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.431 0.634 . . . . 1.71 110.266 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -144.07 85.93 1.83 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.205 -0.665 . . . . 2.56 109.205 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -150.13 30.98 0.69 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.794 0.807 . . . . 4.56 108.911 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.57 -26.16 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.372 -0.831 . . . . 2.52 110.093 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.489 ' O ' HG12 ' A' ' 1' ' ' ILE . 23.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.515 -0.755 . . . . 3.23 109.877 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.3 pt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.033 0.445 . . . . 6.78 111.642 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -115.2 129.39 56.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.695 -0.483 . . . . 7.47 109.695 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.22 -165.74 1.12 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.368 -0.605 . . . . 3.82 109.368 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.73 -36.83 59.83 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.721 0.296 . . . . 2.94 111.204 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 1.1 p -69.1 -8.41 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.766 0.284 . . . . 1.15 111.766 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.16 -28.59 69.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.733 0.301 . . . . 1.33 111.283 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.5 p -79.93 4.19 17.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.873 0.844 . . . . 1.24 109.729 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 14.3 m120 -116.66 106.23 48.6 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.597 -1.183 . . . . 0.43 109.392 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.6 Cg_exo -54.62 -24.18 35.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.198 1.932 . . . . 0.67 112.686 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.82 -35.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.26 110.794 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.85 -37.56 67.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 1.29 110.326 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.797 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.1 ptm180 -82.2 -18.15 43.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.728 1.01 . . . . 2.15 113.728 -172.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.8 m -78.22 -34.14 18.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 111.519 0.192 . . . . 1.52 111.519 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.24 -36.09 14.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.536 -0.465 . . . . 1.71 111.583 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.797 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.66 157.47 30.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.947 0.403 . . . . 2.56 110.183 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 54.96 45.55 26.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.666 . . . . 4.56 111.94 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.78 -15.68 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.799 0.809 . . . . 2.52 108.836 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 12' ' ' ARG . 93.0 m . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.791 -1.095 . . . . 3.23 109.58 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.64 0.257 . . . . 6.78 110.681 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.0 77.14 1.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.217 0.532 . . . . 7.47 110.01 174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.5 t70 -154.83 129.89 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.713 -0.847 . . . . 3.82 108.713 176.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.8 -26.94 60.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 2.94 111.205 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 m -73.62 -8.17 54.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.118 0.414 . . . . 1.15 112.118 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 3' ' ' ASP . 63.5 m -64.97 -37.01 86.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.869 0.366 . . . . 1.33 110.633 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.6 m -89.06 21.04 3.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.844 0.83 . . . . 1.24 109.75 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -127.31 98.48 29.39 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-N 114.891 -1.05 . . . . 0.43 109.13 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.22 -13.74 37.56 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.745 1.63 . . . . 0.67 111.793 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' VAL . 84.1 t -78.81 -32.49 15.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.301 0.572 . . . . 1.26 110.184 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.6 m -72.17 -51.06 23.0 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.898 0.38 . . . . 1.29 110.196 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.703 ' HB3' ' OXT' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.89 -17.67 60.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.621 0.971 . . . . 2.15 113.621 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.1 p -71.09 -38.61 72.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 121.12 -0.232 . . . . 1.52 110.612 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.24 -28.2 14.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.293 0.479 . . . . 1.71 112.293 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 30.0 p30 -68.64 139.03 55.46 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.301 1.048 . . . . 2.56 111.045 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HYP . . . . . 0.409 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -156.93 39.82 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 4.56 111.357 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.63 -73.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.41 . . . . 2.52 110.702 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.703 ' OXT' ' HB3' ' A' ' 12' ' ' ARG . 50.8 t . . . . . 0 C--O 1.252 1.233 0 N-CA-C 108.864 -0.791 . . . . 3.23 108.864 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.788 0.327 . . . . 6.78 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -120.81 37.95 4.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.342 0.592 . . . . 7.47 110.584 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 19.2 m-20 -98.49 30.79 3.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.941 -0.572 . . . . 3.82 110.979 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -67.22 -56.32 10.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 2.94 110.491 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.86 -6.92 23.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 1.15 111.75 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 48.6 t -66.58 -18.89 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.432 0.634 . . . . 1.33 110.548 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -101.96 6.52 41.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.696 -0.684 . . . . 1.24 109.759 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 12.9 m120 -117.15 111.1 40.68 Favored Pre-proline 0 CA--C 1.507 -0.698 0 CA-C-N 115.318 -0.856 . . . . 0.43 109.14 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.1 Cg_endo -62.61 -21.54 73.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.782 1.655 . . . . 0.67 112.433 -172.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.8 t -80.56 -41.38 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.339 -0.391 . . . . 1.26 110.578 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.11 -39.26 81.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.37 0.605 . . . . 1.29 110.665 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 52.3 mtp180 -73.6 -35.18 65.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.957 -1.02 . . . . 2.15 112.112 -172.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 9' ' ' PRO . 20.2 m -84.87 -22.55 7.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.221 -0.899 . . . . 1.52 111.621 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.95 -31.75 20.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.342 0.591 . . . . 1.71 110.119 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -136.8 85.24 2.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.549 -0.751 . . . . 2.56 109.028 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -139.01 56.14 1.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.516 -0.766 . . . . 4.56 109.281 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.73 -33.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 2.52 110.968 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.703 -0.665 . . . . 3.23 109.902 -177.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.936 0.398 . . . . 3.82 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 2.94 110.465 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -70.49 -9.01 55.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.693 -0.685 . . . . 1.15 111.798 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 t -64.65 -31.61 72.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.769 0.318 . . . . 1.33 110.509 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 t -87.0 20.54 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.601 0.715 . . . . 1.24 109.67 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 30.0 m-80 -132.47 111.36 13.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.178 -0.919 . . . . 0.43 109.492 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.43 -13.65 40.91 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.143 1.896 . . . . 0.67 112.487 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 13' ' ' VAL . 23.8 t -84.23 -31.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 1.26 110.315 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 85.5 m -76.33 -50.28 14.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.652 -0.419 . . . . 1.29 110.243 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 19.9 ptt180 -71.15 -17.01 62.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.95 0.722 . . . . 2.15 112.95 -173.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -73.66 -38.82 52.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 110.459 -0.2 . . . . 1.52 110.459 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -87.83 -34.7 18.16 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.346 -0.542 . . . . 1.71 111.514 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.971 0.891 . . . . 2.56 110.129 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.125 0.488 . . . . 4.56 111.294 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.467 ' HB ' ' ND2' ' A' ' 15' ' ' ASN . 44.0 t -83.87 71.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.721 0.772 . . . . 2.52 110.104 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.249 1.048 0 CA-C-N 114.553 -1.203 . . . . 3.23 109.371 175.034 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 121.082 0.468 . . . . 3.82 110.547 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.7 -23.49 59.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.315 0.579 . . . . 2.94 110.447 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HA ' HD22 ' A' ' 8' ' ' ASN . 8.9 p -70.74 -5.32 29.05 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.618 -0.719 . . . . 1.15 111.026 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.54 -27.3 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.748 0.419 . . . . 1.33 111.154 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -89.6 16.97 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.606 0.717 . . . . 1.24 109.825 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.515 HD22 ' HA ' ' A' ' 5' ' ' CYS . 24.0 m-80 -130.03 102.15 17.67 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.731 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.8 Cg_exo -56.21 -22.13 39.03 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.028 1.819 . . . . 0.67 112.305 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.57 -29.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.684 0.754 . . . . 1.26 110.394 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -76.68 -43.65 36.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.545 -0.752 . . . . 1.29 110.541 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -79.64 -16.21 56.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.135 0.791 . . . . 2.15 113.135 -171.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' PRO . 11.0 m -75.31 -43.61 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.601 0.239 . . . . 1.52 111.348 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -80.81 -37.34 30.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.989 0.423 . . . . 1.71 109.961 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.496 HD22 HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 108.681 -0.859 . . . . 2.56 108.681 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.913 0.338 . . . . 4.56 111.913 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 15' ' ' ASN . 35.8 m -76.67 -10.87 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.677 0.751 . . . . 2.52 109.395 169.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.468 -1.242 . . . . 3.23 108.852 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 121.009 0.433 . . . . 3.82 111.097 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -60.52 -12.66 10.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.6 -0.727 . . . . 2.94 110.514 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 m -58.92 -11.73 3.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.653 -0.703 . . . . 1.15 112.757 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.28 -40.84 98.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.725 0.298 . . . . 1.33 111.418 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 p -91.87 -8.25 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.229 0.538 . . . . 1.24 110.713 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 23.9 m-80 -97.03 100.63 7.88 Favored Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.567 -0.742 . . . . 0.43 109.123 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 19.2 Cg_endo -56.51 -23.27 46.95 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.895 1.73 . . . . 0.67 112.552 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 -38.06 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.477 0.656 . . . . 1.26 110.378 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.8 m -63.58 -47.67 80.57 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.312 -0.858 . . . . 1.29 110.858 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG3' ' HA ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -71.63 -25.27 62.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 2.15 111.971 -172.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 9' ' ' PRO . 18.5 m -88.78 -25.7 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 112.184 0.439 . . . . 1.52 112.184 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -85.14 -36.43 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.532 0.682 . . . . 1.71 109.864 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HG12 ' A' ' 18' ' ' VAL . 50.7 t30 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.07 -0.968 . . . . 2.56 109.148 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.93 0.395 . . . . 4.56 110.621 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 15' ' ' ASN . 7.2 p -114.08 76.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.272 1.034 . . . . 2.52 110.585 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.157 -0.929 . . . . 3.23 110.095 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.382 0.61 . . . . 3.82 109.938 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.29 9.76 31.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.606 -0.725 . . . . 2.94 111.554 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.5 m -61.35 -12.61 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.775 0.322 . . . . 1.15 111.755 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.51 -32.76 74.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.327 -0.397 . . . . 1.33 110.401 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -89.18 11.68 18.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.364 0.602 . . . . 1.24 110.277 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.3 m-80 -135.04 97.29 13.72 Favored Pre-proline 0 CA--C 1.508 -0.655 0 CA-C-N 115.574 -0.739 . . . . 0.43 109.609 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.81 -18.74 22.52 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.407 2.072 . . . . 0.67 113.011 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.75 -42.47 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 1.26 110.201 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.83 -35.52 38.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.738 -0.665 . . . . 1.29 111.576 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.0 ptm180 -70.16 -26.37 63.89 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.089 -0.644 . . . . 2.15 111.469 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 -58.92 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.704 -0.68 . . . . 1.52 112.559 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.15 -44.32 89.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.946 0.403 . . . . 1.71 110.606 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.452 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 108.933 -0.766 . . . . 2.56 108.933 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 50.9 m80 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.355 0.502 . . . . 4.56 112.355 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 15' ' ' ASN . 55.8 t 70.43 -52.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.05 0.54 . . . . 2.52 111.224 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 119.003 -0.523 . . . . 3.23 110.339 176.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 6' ' ' CYS . 5.3 p-10 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.597 0.713 . . . . 3.82 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.02 -46.96 72.89 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.131 -0.941 . . . . 2.94 110.249 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' HA ' HD22 ' A' ' 8' ' ' ASN . 12.0 m -65.03 -16.54 63.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.14 -0.482 . . . . 1.15 112.068 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 14.4 m -59.84 -26.37 65.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.806 0.299 . . . . 1.33 111.806 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.8 m -93.39 9.52 36.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.551 0.691 . . . . 1.24 110.229 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 25.3 m-80 -127.94 92.54 41.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.339 -0.846 . . . . 0.43 109.286 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.35 -24.01 25.96 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.334 2.022 . . . . 0.67 112.946 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.8 p -79.88 -33.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.85 0.833 . . . . 1.26 110.172 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t -73.96 -39.67 63.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.301 -0.863 . . . . 1.29 110.11 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.7 ptt180 -83.47 -27.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.752 1.019 . . . . 2.15 113.752 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 10' ' ' VAL . 11.3 p -59.68 -37.08 69.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 1.52 110.435 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -76.28 -42.79 44.3 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.545 0.688 . . . . 1.71 110.041 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.431 HD22 ' HB ' ' A' ' 18' ' ' VAL . 3.6 t30 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.041 -0.982 . . . . 2.56 109.805 -165.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.391 0.615 . . . . 4.56 109.591 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.431 ' HB ' HD22 ' A' ' 15' ' ' ASN . 11.7 p -83.76 -29.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.378 -0.828 . . . . 2.52 111.666 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.636 -0.697 . . . . 3.23 110.141 -179.149 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 122.126 0.965 . . . . 3.82 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.2 -29.7 70.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.111 -1.404 . . . . 2.94 110.987 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -17.26 64.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.504 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -61.04 -35.42 76.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.703 0.287 . . . . 1.33 111.394 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 t -83.44 -6.4 59.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.669 . . . . 1.24 109.743 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -99.67 107.37 45.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.083 -0.962 . . . . 0.43 109.62 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 25.7 Cg_endo -60.55 -18.28 53.54 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.753 1.636 . . . . 0.67 112.7 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.4 p -75.58 -31.63 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 1.26 110.177 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 46.4 t -72.77 -48.85 34.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.606 -0.725 . . . . 1.29 110.151 177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HA ' HD22 ' A' ' 15' ' ' ASN . 16.7 ptt180 -76.91 -17.79 58.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.282 0.845 . . . . 2.15 113.282 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 10' ' ' VAL . 12.1 p -75.11 -32.61 26.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.519 0.2 . . . . 1.52 110.933 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -102.95 -39.2 7.03 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.545 -0.462 . . . . 1.71 111.84 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.569 HD22 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.768 0.794 . . . . 2.56 111.182 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.864 0.364 . . . . 4.56 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.9 -41.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.38 -0.819 . . . . 3.23 109.667 176.328 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 121.783 0.802 . . . . 3.82 110.054 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.25 -22.73 12.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.278 -0.874 . . . . 2.94 110.364 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.73 -5.75 32.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 1.15 111.97 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.19 -36.25 83.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.722 0.296 . . . . 1.33 110.789 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -89.51 6.08 42.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.58 0.705 . . . . 1.24 109.64 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.569 HD22 ' N ' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -113.98 91.48 22.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.758 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.21 -27.01 45.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.229 1.953 . . . . 0.67 112.397 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -47.18 93.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.598 -0.274 . . . . 1.26 110.289 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.43 -56.85 16.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.105 -0.498 . . . . 1.29 111.329 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 9.2 ptm180 -65.22 -18.05 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.572 -0.74 . . . . 2.15 112.831 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.74 -47.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 112.285 0.476 . . . . 1.52 112.285 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.59 -25.2 56.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.29 -0.564 . . . . 1.71 110.457 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.816 -0.629 . . . . 2.56 109.818 -178.39 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.8 m170 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.941 0.401 . . . . 4.56 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.01 -16.26 7.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.58 0.705 . . . . 2.52 110.205 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.67 -0.681 . . . . 3.23 109.756 -179.19 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.489 0.661 . . . . 3.82 110.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -62.52 -62.8 1.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.525 -0.761 . . . . 2.94 111.789 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 m -72.02 -7.7 50.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.15 111.677 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.07 -31.22 68.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.165 -0.471 . . . . 1.33 110.709 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -85.32 2.87 42.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.729 0.775 . . . . 1.24 109.822 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -124.0 89.5 51.62 Favored Pre-proline 0 CA--C 1.508 -0.649 0 CA-C-N 114.983 -1.008 . . . . 0.43 109.333 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 13' ' ' VAL . 50.1 Cg_exo -56.17 -18.88 25.13 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.55 2.167 . . . . 0.67 112.803 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.39 -32.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.587 0.708 . . . . 1.26 110.305 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 34.6 t -75.7 -43.47 47.05 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.334 -0.546 . . . . 1.29 109.709 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.693 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 ptm180 -72.83 -17.48 61.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.472 0.915 . . . . 2.15 113.472 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 9' ' ' PRO . 8.2 m -82.56 -33.22 10.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.705 -0.225 . . . . 1.52 111.404 175.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 p30 -89.61 -33.55 16.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.475 -0.49 . . . . 1.71 111.476 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.693 ' OD1' ' HA ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.242 0.544 . . . . 2.56 111.684 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 . . . . . 0 C--O 1.232 0.174 0 N-CA-C 109.765 -0.457 . . . . 4.56 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG22 ' CG ' ' A' ' 15' ' ' ASN . 2.9 m -90.42 3.15 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.257 0.551 . . . . 2.52 110.855 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.305 -0.855 . . . . 3.23 109.404 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.312 0.577 . . . . 3.82 110.058 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.27 -46.31 2.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.8 -0.636 . . . . 2.94 110.856 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' C ' ' HB2' ' A' ' 19' ' ' CYS . 1.7 m -92.46 -7.03 48.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.122 -0.49 . . . . 1.15 111.3 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 19' ' ' CYS . 49.9 m -67.3 -25.19 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.465 -0.334 . . . . 1.33 111.467 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -90.51 14.47 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 1.24 109.454 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.563 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 23.7 m-80 -130.25 94.74 29.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.107 -0.951 . . . . 0.43 109.057 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.442 ' O ' HG13 ' A' ' 13' ' ' VAL . 28.7 Cg_endo -60.11 -16.13 37.97 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.362 2.041 . . . . 0.67 112.818 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.74 -39.01 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 1.26 110.366 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 t -71.57 -35.16 70.48 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.51 -0.476 . . . . 1.29 110.367 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 14.4 ptm180 -82.17 -17.82 44.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.018 1.118 . . . . 2.15 114.018 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 9' ' ' PRO . 3.7 m -71.69 -33.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 O-C-N 121.89 -0.506 . . . . 1.52 111.045 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.67 -50.77 63.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.228 -0.589 . . . . 1.71 110.121 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 N--CA 1.434 -1.252 0 CA-C-N 115.448 -0.796 . . . . 2.56 111.653 -172.615 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 121.403 0.62 . . . . 4.56 110.468 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.33 69.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.509 -0.923 . . . . 2.52 108.509 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 2.1 p . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.036 -0.984 . . . . 3.23 111.585 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.194 0.521 . . . . 3.82 110.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.87 -55.14 4.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.802 -0.635 . . . . 2.94 110.274 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.529 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.6 p -68.34 -10.37 54.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 1.15 110.728 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 34.3 t -63.31 -26.9 68.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 1.33 110.697 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -85.48 7.17 23.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.443 0.639 . . . . 1.24 110.1 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.2 m-80 -115.84 114.93 41.59 Favored Pre-proline 0 CA--C 1.513 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.43 109.78 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 -15.61 47.99 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.078 1.852 . . . . 0.67 112.99 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -83.98 -28.35 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 1.26 110.475 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 46.6 t -82.36 -44.0 16.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.702 -0.799 . . . . 1.29 110.428 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 15' ' ' ASN . 13.7 ptt180 -72.13 -17.76 61.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.949 0.722 . . . . 2.15 112.949 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.43 -40.71 42.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.505 -0.316 . . . . 1.52 110.852 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 8.5 p30 -88.06 -30.61 19.79 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.382 -0.527 . . . . 1.71 111.144 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.601 ' CG ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 122.148 0.975 . . . . 2.56 110.628 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 m80 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 111.678 0.251 . . . . 4.56 111.678 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.601 HG12 ' CG ' ' A' ' 15' ' ' ASN . 4.3 p -93.02 -30.98 4.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.667 -0.813 . . . . 2.52 108.934 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.1 -0.955 . . . . 3.23 108.694 174.067 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.651 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 5.1 m-20 . . . . . 0 C--O 1.236 0.351 0 CA-C-O 120.928 0.394 . . . . 3.82 111.346 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.16 -62.43 1.38 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.946 -0.57 . . . . 2.94 110.782 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.9 m -60.15 -25.78 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.446 . . . . 1.15 111.843 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.0 m -62.54 -28.74 70.06 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 1.33 111.116 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t -91.45 -5.34 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 1.24 110.22 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.6 m-80 -118.98 102.75 48.84 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-N 115.646 -0.706 . . . . 0.43 109.946 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.31 -18.36 37.57 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.169 1.913 . . . . 0.67 113.034 -175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 13' ' ' VAL . 9.8 p -80.6 -37.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.519 0.676 . . . . 1.26 110.666 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 13.2 t -76.46 -42.27 44.36 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.998 -0.681 . . . . 1.29 110.141 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 12.0 ptm180 -73.38 -26.23 60.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.026 0.75 . . . . 2.15 113.026 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -66.95 -40.81 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.696 0.284 . . . . 1.52 111.294 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' HG13 ' A' ' 13' ' ' VAL . 8.0 p30 -90.11 -21.9 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 1.71 110.888 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.696 0.76 . . . . 2.56 111.141 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.9 m80 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.204 0.526 . . . . 4.56 111.442 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.56 -42.55 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.009 -0.738 . . . . 2.52 109.009 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 3' ' ' ASP . 49.8 t . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.657 -1.156 . . . . 3.23 108.184 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 121.084 0.468 . . . . 3.82 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.59 11.7 38.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 2.94 111.205 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HA ' HD22 ' A' ' 8' ' ' ASN . 0.8 OUTLIER -68.61 -6.49 26.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.49 -177.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.4 m -60.41 -26.02 66.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 1.33 111.099 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -87.03 15.93 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.856 0.836 . . . . 1.24 109.287 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.568 HD22 ' HA ' ' A' ' 5' ' ' CYS . 16.9 m-80 -129.77 97.88 23.21 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 114.728 -1.123 . . . . 0.43 108.121 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.492 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -54.3 -25.61 39.6 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.197 1.932 . . . . 0.67 112.679 -174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -73.76 -35.18 42.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.975 0.417 . . . . 1.26 110.396 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -67.98 -40.23 83.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 1.29 110.428 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 11.9 ptm180 -82.49 -34.14 28.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.498 0.925 . . . . 2.15 113.498 -171.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.7 m -58.82 -48.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 111.749 0.277 . . . . 1.52 111.749 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.419 HD22 ' C ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -91.81 -3.05 56.59 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.716 -0.394 . . . . 1.71 111.961 -176.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 2.56 110.529 179.226 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 m80 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 112.011 0.374 . . . . 4.56 112.011 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 p -58.98 -32.26 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.921 0.391 . . . . 2.52 111.09 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 24.5 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.87 -0.586 . . . . 3.23 110.039 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.53 0.681 . . . . 3.82 110.621 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.04 -23.93 60.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.754 -1.112 . . . . 2.94 110.751 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -64.37 -14.75 58.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.468 0.544 . . . . 1.15 112.468 -172.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.55 -37.82 80.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 1.33 110.597 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.8 t -82.71 4.95 22.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.649 0.737 . . . . 1.24 109.8 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.29 107.64 47.01 Favored Pre-proline 0 CA--C 1.509 -0.614 0 CA-C-N 115.12 -0.945 . . . . 0.43 109.482 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.58 -20.5 70.92 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.622 1.548 . . . . 0.67 111.935 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -73.83 -31.29 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.396 0.617 . . . . 1.26 109.639 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 73.9 m -76.19 -56.28 4.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.82 -0.627 . . . . 1.29 110.595 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -63.6 -19.22 64.67 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.907 0.706 . . . . 2.15 112.907 -173.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -89.78 -35.51 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 112.336 0.495 . . . . 1.52 112.336 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 2.4 p30 -80.13 -31.13 39.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.131 -0.628 . . . . 1.71 110.063 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 109.328 -0.619 . . . . 2.56 109.328 176.258 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.305 0.574 . . . . 4.56 110.624 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.51 -32.31 49.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.805 -0.634 . . . . 2.52 110.169 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.707 -0.663 . . . . 3.23 109.464 175.847 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.236 0.541 . . . . 3.82 111.789 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.8 -20.34 61.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.629 -0.714 . . . . 2.94 110.847 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -61.55 -8.2 4.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.153 -0.476 . . . . 1.15 112.084 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.1 -33.32 73.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.995 0.426 . . . . 1.33 110.241 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -85.32 1.1 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 1.24 109.719 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -119.52 90.69 43.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.676 -1.147 . . . . 0.43 108.771 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.573 ' O ' HG13 ' A' ' 13' ' ' VAL . 18.5 Cg_endo -56.73 -22.16 43.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.134 1.89 . . . . 0.67 112.495 -174.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.67 -31.85 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.522 0.677 . . . . 1.26 110.077 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HA ' HD21 ' A' ' 14' ' ' ASN . 38.3 t -76.72 -32.79 58.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.099 -0.5 . . . . 1.29 110.286 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -83.12 -21.56 33.59 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.515 0.932 . . . . 2.15 113.515 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 9' ' ' PRO . 16.3 m -72.33 -36.14 54.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 111.76 0.282 . . . . 1.52 111.76 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 11' ' ' CYS . 9.6 p30 -87.27 -10.05 53.4 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.594 -0.442 . . . . 1.71 110.575 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 115.811 -0.631 . . . . 2.56 109.329 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.044 0.45 . . . . 4.56 110.562 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.734 -0.469 . . . . 2.52 109.734 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.253 1.255 0 CA-C-N 115.605 -0.725 . . . . 3.23 109.152 178.231 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 121.206 0.527 . . . . 3.82 111.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.0 -14.55 60.63 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.495 -0.775 . . . . 2.94 110.065 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 1.5 m -63.45 -7.6 7.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.016 -0.538 . . . . 1.15 112.408 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.3 m -65.09 -37.2 86.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.484 -0.562 . . . . 1.33 109.484 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -87.58 7.23 30.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.635 -0.711 . . . . 1.24 109.98 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 17.6 m-80 -120.7 93.24 48.5 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-N 115.186 -0.915 . . . . 0.43 108.925 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.85 -22.78 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.047 1.831 . . . . 0.67 112.511 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 11' ' ' CYS . 14.0 p -64.1 -46.89 92.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 1.26 110.216 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.42 ' N ' HG13 ' A' ' 10' ' ' VAL . 81.0 m -61.72 -55.39 30.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.755 . . . . 1.29 111.154 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -70.38 -16.71 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.158 0.799 . . . . 2.15 113.158 -171.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.09 -40.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.145 0.424 . . . . 1.52 112.145 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.32 -25.11 42.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.915 -0.714 . . . . 1.71 109.755 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 108.988 -0.745 . . . . 2.56 108.988 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 108.324 -0.991 . . . . 4.56 108.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.55 -29.14 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.274 -0.875 . . . . 2.52 110.421 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-N 116.092 -0.503 . . . . 3.23 110.209 175.388 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.0 t70 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 108.859 -0.793 . . . . 3.82 108.859 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.87 -16.38 63.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.363 -0.38 . . . . 2.94 111.607 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.681 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -66.82 -10.07 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.15 110.896 177.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.6 t -63.79 -32.41 73.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.124 -0.489 . . . . 1.33 110.133 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 t -88.77 17.15 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.538 0.685 . . . . 1.24 110.105 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 27.2 m-80 -132.93 104.68 12.71 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-N 115.579 -0.737 . . . . 0.43 109.974 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.559 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -56.9 -24.44 56.62 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.895 1.73 . . . . 0.67 112.196 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.44 -33.53 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.828 0.823 . . . . 1.26 110.301 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.8 m -73.83 -43.38 58.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.532 -0.758 . . . . 1.29 109.946 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 28.9 mtp180 -68.71 -38.95 80.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.234 -0.894 . . . . 2.15 112.898 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' PRO . 15.8 m -63.5 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.806 -0.634 . . . . 1.52 112.205 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -87.13 -34.49 19.07 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.654 -0.418 . . . . 1.71 111.281 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 121.945 0.879 . . . . 2.56 110.554 178.561 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 CA--C 1.523 -0.058 0 CA-C-O 121.096 0.474 . . . . 4.56 111.399 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.75 -28.04 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.163 0.506 . . . . 2.52 110.318 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.732 . . . . 3.23 109.672 176.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.814 -0.439 . . . . 3.82 109.814 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.66 -20.29 33.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.116 -0.493 . . . . 2.94 110.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -17.74 62.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.15 110.808 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 46.6 t -59.72 -36.36 76.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.86 -0.609 . . . . 1.33 111.323 174.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -84.16 -6.82 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.433 0.635 . . . . 1.24 109.797 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 24.8 m-80 -99.63 111.61 61.94 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.43 110.125 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.88 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.716 1.611 . . . . 0.67 112.442 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.91 -42.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.494 0.664 . . . . 1.26 110.035 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -69.44 -52.6 25.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 1.29 111.374 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 8.7 ptm180 -64.94 -21.02 66.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.942 0.719 . . . . 2.15 112.942 -175.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 t -88.65 -38.52 11.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.035 0.445 . . . . 1.52 111.943 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -81.33 -21.2 39.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.431 0.634 . . . . 1.71 110.266 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.494 HD22 ' HB ' ' A' ' 18' ' ' VAL . 6.6 t30 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 109.205 -0.665 . . . . 2.56 109.205 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.794 0.807 . . . . 4.56 108.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.494 ' HB ' HD22 ' A' ' 15' ' ' ASN . 9.4 p -87.57 -26.16 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.372 -0.831 . . . . 2.52 110.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.515 -0.755 . . . . 3.23 109.877 -179.456 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 109.368 -0.605 . . . . 3.82 109.368 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.73 -36.83 59.83 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.721 0.296 . . . . 2.94 111.204 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HA ' HD22 ' A' ' 8' ' ' ASN . 1.1 p -69.1 -8.41 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.766 0.284 . . . . 1.15 111.766 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.16 -28.59 69.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.733 0.301 . . . . 1.33 111.283 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.5 p -79.93 4.19 17.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.873 0.844 . . . . 1.24 109.729 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 5' ' ' CYS . 26.3 m-80 -116.66 106.23 48.6 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.597 -1.183 . . . . 0.43 109.392 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.6 Cg_exo -54.62 -24.18 35.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.198 1.932 . . . . 0.67 112.686 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.82 -35.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.26 110.794 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.85 -37.56 67.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 1.29 110.326 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.797 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.1 ptm180 -82.2 -18.15 43.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.728 1.01 . . . . 2.15 113.728 -172.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.8 m -78.22 -34.14 18.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 111.519 0.192 . . . . 1.52 111.519 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.24 -36.09 14.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.536 -0.465 . . . . 1.71 111.583 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.797 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 120.947 0.403 . . . . 2.56 110.183 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 111.94 0.348 . . . . 4.56 111.94 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.78 -15.68 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.799 0.809 . . . . 2.52 108.836 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 12' ' ' ARG . 93.0 m . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.791 -1.095 . . . . 3.23 109.58 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.5 t70 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 108.713 -0.847 . . . . 3.82 108.713 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.8 -26.94 60.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 2.94 111.205 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 m -73.62 -8.17 54.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.118 0.414 . . . . 1.15 112.118 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 3' ' ' ASP . 63.5 m -64.97 -37.01 86.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.869 0.366 . . . . 1.33 110.633 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.6 m -89.06 21.04 3.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.844 0.83 . . . . 1.24 109.75 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -127.31 98.48 29.39 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-N 114.891 -1.05 . . . . 0.43 109.13 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.22 -13.74 37.56 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.745 1.63 . . . . 0.67 111.793 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' VAL . 84.1 t -78.81 -32.49 15.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.301 0.572 . . . . 1.26 110.184 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.6 m -72.17 -51.06 23.0 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.898 0.38 . . . . 1.29 110.196 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.703 ' HB3' ' OXT' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.89 -17.67 60.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.621 0.971 . . . . 2.15 113.621 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.1 p -71.09 -38.61 72.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 121.12 -0.232 . . . . 1.52 110.612 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.24 -28.2 14.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.293 0.479 . . . . 1.71 112.293 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 30.0 p30 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 122.301 1.048 . . . . 2.56 111.045 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.0 p80 . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.821 0.343 . . . . 4.56 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.63 -73.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.41 . . . . 2.52 110.702 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.703 ' OXT' ' HB3' ' A' ' 12' ' ' ARG . 50.8 t . . . . . 0 C--O 1.252 1.233 0 N-CA-C 108.864 -0.791 . . . . 3.23 108.864 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 19.2 m-20 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.889 0.376 . . . . 3.82 110.979 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -67.22 -56.32 10.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 2.94 110.491 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.558 ' HA ' HD22 ' A' ' 8' ' ' ASN . 1.2 m -67.86 -6.92 23.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 1.15 111.75 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 48.6 t -66.58 -18.89 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.432 0.634 . . . . 1.33 110.548 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -101.96 6.52 41.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.696 -0.684 . . . . 1.24 109.759 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.558 HD22 ' HA ' ' A' ' 5' ' ' CYS . 20.2 m-80 -117.15 111.1 40.68 Favored Pre-proline 0 CA--C 1.507 -0.698 0 CA-C-N 115.318 -0.856 . . . . 0.43 109.14 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.1 Cg_endo -62.61 -21.54 73.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.782 1.655 . . . . 0.67 112.433 -172.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.8 t -80.56 -41.38 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.339 -0.391 . . . . 1.26 110.578 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.11 -39.26 81.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.37 0.605 . . . . 1.29 110.665 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 52.3 mtp180 -73.6 -35.18 65.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.957 -1.02 . . . . 2.15 112.112 -172.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 9' ' ' PRO . 20.2 m -84.87 -22.55 7.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.221 -0.899 . . . . 1.52 111.621 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.95 -31.75 20.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.342 0.591 . . . . 1.71 110.119 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.549 -0.751 . . . . 2.56 109.028 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.0 m80 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.281 -0.637 . . . . 4.56 109.281 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.73 -33.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 2.52 110.968 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.703 -0.665 . . . . 3.23 109.902 -177.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 6.78 109.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 6.7 tpm_? -172.85 47.85 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.6 -1.182 . . . . 7.47 108.636 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.98 67.41 7.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.751 . . . . 3.82 110.778 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.159 0.504 . . . . 2.94 110.465 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -70.49 -9.01 55.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.693 -0.685 . . . . 1.15 111.798 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 t -64.65 -31.61 72.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.769 0.318 . . . . 1.33 110.509 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 t -87.0 20.54 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.601 0.715 . . . . 1.24 109.67 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 30.0 m-80 -132.47 111.36 13.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.178 -0.919 . . . . 0.43 109.492 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.43 -13.65 40.91 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.143 1.896 . . . . 0.67 112.487 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 13' ' ' VAL . 23.8 t -84.23 -31.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 1.26 110.315 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 85.5 m -76.33 -50.28 14.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 120.652 -0.419 . . . . 1.29 110.243 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 19.9 ptt180 -71.15 -17.01 62.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.95 0.722 . . . . 2.15 112.95 -173.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.7 p -73.66 -38.82 52.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 110.459 -0.2 . . . . 1.52 110.459 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -87.83 -34.7 18.16 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.346 -0.542 . . . . 1.71 111.514 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' A' ' 18' ' ' VAL . 7.2 p30 -81.0 141.02 34.83 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.971 0.891 . . . . 2.56 110.129 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -163.89 45.22 0.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 4.56 111.294 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.467 ' HB ' ' ND2' ' A' ' 15' ' ' ASN . 44.0 t -83.87 71.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.721 0.772 . . . . 2.52 110.104 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.249 1.048 0 CA-C-N 114.553 -1.203 . . . . 3.23 109.371 175.034 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.767 0.317 . . . . 6.78 110.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -138.95 127.91 23.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 110.009 -0.367 . . . . 7.47 110.009 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -76.58 77.2 3.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.082 0.468 . . . . 3.82 110.547 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.7 -23.49 59.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.315 0.579 . . . . 2.94 110.447 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HA ' HD22 ' A' ' 8' ' ' ASN . 8.9 p -70.74 -5.32 29.05 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.618 -0.719 . . . . 1.15 111.026 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.54 -27.3 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.748 0.419 . . . . 1.33 111.154 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -89.6 16.97 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.606 0.717 . . . . 1.24 109.825 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.515 HD22 ' HA ' ' A' ' 5' ' ' CYS . 24.0 m-80 -130.03 102.15 17.67 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.731 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.8 Cg_exo -56.21 -22.13 39.03 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.028 1.819 . . . . 0.67 112.305 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.57 -29.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.684 0.754 . . . . 1.26 110.394 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.7 t -76.68 -43.65 36.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.545 -0.752 . . . . 1.29 110.541 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -79.64 -16.21 56.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.135 0.791 . . . . 2.15 113.135 -171.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' PRO . 11.0 m -75.31 -43.61 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.601 0.239 . . . . 1.52 111.348 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 16' ' ' HYP . 4.9 p30 -80.81 -37.34 30.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.989 0.423 . . . . 1.71 109.961 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.496 HD22 HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -94.61 103.62 15.56 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.681 -0.859 . . . . 2.56 108.681 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 60.22 41.13 17.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.601 -1.182 . . . . 4.56 111.913 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 15' ' ' ASN . 35.8 m -76.67 -10.87 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.677 0.751 . . . . 2.52 109.395 169.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.468 -1.242 . . . . 3.23 108.852 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.824 0.345 . . . . 6.78 110.687 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 3.4 mmp_? -83.67 140.35 32.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.484 . . . . 7.47 109.91 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.26 99.92 10.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 3.82 111.097 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -60.52 -12.66 10.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.6 -0.727 . . . . 2.94 110.514 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 m -58.92 -11.73 3.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.653 -0.703 . . . . 1.15 112.757 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.28 -40.84 98.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.725 0.298 . . . . 1.33 111.418 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 p -91.87 -8.25 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.229 0.538 . . . . 1.24 110.713 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 23.9 m-80 -97.03 100.63 7.88 Favored Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.567 -0.742 . . . . 0.43 109.123 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 12' ' ' ARG . 19.2 Cg_endo -56.51 -23.27 46.95 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.895 1.73 . . . . 0.67 112.552 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 -38.06 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.477 0.656 . . . . 1.26 110.378 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.8 m -63.58 -47.67 80.57 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.312 -0.858 . . . . 1.29 110.858 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG3' ' HA ' ' A' ' 9' ' ' PRO . 0.9 OUTLIER -71.63 -25.27 62.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 2.15 111.971 -172.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 9' ' ' PRO . 18.5 m -88.78 -25.7 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 112.184 0.439 . . . . 1.52 112.184 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -85.14 -36.43 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.532 0.682 . . . . 1.71 109.864 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HG12 ' A' ' 18' ' ' VAL . 50.7 t30 -140.16 88.31 2.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.07 -0.968 . . . . 2.56 109.148 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -165.67 27.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.606 -0.725 . . . . 4.56 110.621 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 15' ' ' ASN . 7.2 p -114.08 76.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.272 1.034 . . . . 2.52 110.585 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.157 -0.929 . . . . 3.23 110.095 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.778 -0.452 . . . . 6.78 109.778 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -128.3 140.35 51.93 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.487 -0.561 . . . . 7.47 109.487 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -78.67 84.05 4.79 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.382 0.61 . . . . 3.82 109.938 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.29 9.76 31.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.606 -0.725 . . . . 2.94 111.554 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.5 m -61.35 -12.61 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.775 0.322 . . . . 1.15 111.755 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.51 -32.76 74.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.327 -0.397 . . . . 1.33 110.401 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -89.18 11.68 18.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.364 0.602 . . . . 1.24 110.277 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.3 m-80 -135.04 97.29 13.72 Favored Pre-proline 0 CA--C 1.508 -0.655 0 CA-C-N 115.574 -0.739 . . . . 0.43 109.609 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.81 -18.74 22.52 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.407 2.072 . . . . 0.67 113.011 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.75 -42.47 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 1.26 110.201 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.83 -35.52 38.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.738 -0.665 . . . . 1.29 111.576 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.0 ptm180 -70.16 -26.37 63.89 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.089 -0.644 . . . . 2.15 111.469 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 -58.92 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.704 -0.68 . . . . 1.52 112.559 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -65.15 -44.32 89.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.946 0.403 . . . . 1.71 110.606 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.546 ' ND2' HD22 ' A' ' 16' ' ' HYP . 0.7 OUTLIER -88.51 157.01 18.77 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.933 -0.766 . . . . 2.56 108.933 172.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.546 HD22 ' ND2' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 50.9 m80 75.29 -47.9 0.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.171 -0.922 . . . . 4.56 112.355 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 15' ' ' ASN . 55.8 t 70.43 -52.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.05 0.54 . . . . 2.52 111.224 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.25 1.08 0 CA-C-O 119.003 -0.523 . . . . 3.23 110.339 176.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.556 ' HB ' ' OD1' ' A' ' 3' ' ' ASP . 33.1 pt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.749 0.309 . . . . 6.78 110.556 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 2' ' ' ARG . 33.4 mtm180 -102.52 12.04 37.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.465 0.65 . . . . 7.47 110.533 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.556 ' OD1' ' HB ' ' A' ' 1' ' ' ILE . 5.3 p-10 -109.72 41.02 1.77 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.121 -0.945 . . . . 3.82 111.09 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.02 -46.96 72.89 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.131 -0.941 . . . . 2.94 110.249 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' HA ' HD22 ' A' ' 8' ' ' ASN . 12.0 m -65.03 -16.54 63.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.14 -0.482 . . . . 1.15 112.068 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 14.4 m -59.84 -26.37 65.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.806 0.299 . . . . 1.33 111.806 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.8 m -93.39 9.52 36.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.551 0.691 . . . . 1.24 110.229 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 25.3 m-80 -127.94 92.54 41.9 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.339 -0.846 . . . . 0.43 109.286 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.35 -24.01 25.96 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.334 2.022 . . . . 0.67 112.946 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.8 p -79.88 -33.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.85 0.833 . . . . 1.26 110.172 -175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.9 t -73.96 -39.67 63.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.301 -0.863 . . . . 1.29 110.11 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 11.7 ptt180 -83.47 -27.61 29.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.752 1.019 . . . . 2.15 113.752 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 10' ' ' VAL . 11.3 p -59.68 -37.08 69.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 1.52 110.435 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -76.28 -42.79 44.3 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.545 0.688 . . . . 1.71 110.041 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.431 HD22 ' HB ' ' A' ' 18' ' ' VAL . 3.6 t30 -136.09 85.11 2.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.041 -0.982 . . . . 2.56 109.805 -165.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -122.41 35.22 4.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.391 0.615 . . . . 4.56 109.591 172.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.431 ' HB ' HD22 ' A' ' 15' ' ' ASN . 11.7 p -83.76 -29.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.378 -0.828 . . . . 2.52 111.666 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.636 -0.697 . . . . 3.23 110.141 -179.149 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.8 tt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.747 0.308 . . . . 6.78 110.369 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -80.75 88.72 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.096 0.475 . . . . 7.47 110.081 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -13.76 61.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.126 0.965 . . . . 3.82 110.385 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.2 -29.7 70.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.111 -1.404 . . . . 2.94 110.987 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -17.26 64.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.504 -173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -61.04 -35.42 76.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.703 0.287 . . . . 1.33 111.394 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 t -83.44 -6.4 59.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.669 . . . . 1.24 109.743 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -99.67 107.37 45.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.083 -0.962 . . . . 0.43 109.62 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 25.7 Cg_endo -60.55 -18.28 53.54 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.753 1.636 . . . . 0.67 112.7 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.4 p -75.58 -31.63 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 1.26 110.177 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 46.4 t -72.77 -48.85 34.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.606 -0.725 . . . . 1.29 110.151 177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HA ' HD22 ' A' ' 15' ' ' ASN . 16.7 ptt180 -76.91 -17.79 58.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.282 0.845 . . . . 2.15 113.282 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 10' ' ' VAL . 12.1 p -75.11 -32.61 26.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.519 0.2 . . . . 1.52 110.933 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -102.95 -39.2 7.03 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.545 -0.462 . . . . 1.71 111.84 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.569 HD22 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -70.19 144.5 51.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.768 0.794 . . . . 2.56 111.182 -177.041 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -147.29 48.5 1.12 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.864 0.364 . . . . 4.56 110.776 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -76.9 -41.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.38 -0.819 . . . . 3.23 109.667 176.328 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.2 pt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.934 0.397 . . . . 6.78 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -157.27 -175.6 5.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.138 -0.483 . . . . 7.47 109.844 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 58.31 32.8 22.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.783 0.802 . . . . 3.82 110.054 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.25 -22.73 12.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.278 -0.874 . . . . 2.94 110.364 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.73 -5.75 32.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 1.15 111.97 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.19 -36.25 83.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.722 0.296 . . . . 1.33 110.789 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -89.51 6.08 42.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.58 0.705 . . . . 1.24 109.64 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.569 HD22 ' N ' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -113.98 91.48 22.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.912 -1.04 . . . . 0.43 108.758 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.21 -27.01 45.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.229 1.953 . . . . 0.67 112.397 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.32 -47.18 93.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.598 -0.274 . . . . 1.26 110.289 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.43 -56.85 16.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.105 -0.498 . . . . 1.29 111.329 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 9.2 ptm180 -65.22 -18.05 64.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.572 -0.74 . . . . 2.15 112.831 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.74 -47.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 112.285 0.476 . . . . 1.52 112.285 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.59 -25.2 56.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.29 -0.564 . . . . 1.71 110.457 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -134.98 89.48 2.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.816 -0.629 . . . . 2.56 109.818 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -144.41 18.32 1.7 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.135 -0.484 . . . . 4.56 110.468 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.01 -16.26 7.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.58 0.705 . . . . 2.52 110.205 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.67 -0.681 . . . . 3.23 109.756 -179.19 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.284 -0.265 . . . . 6.78 110.284 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -79.0 127.11 31.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 7.47 110.262 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -92.94 15.21 15.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.489 0.661 . . . . 3.82 110.533 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -62.52 -62.8 1.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.525 -0.761 . . . . 2.94 111.789 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 m -72.02 -7.7 50.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.966 0.412 . . . . 1.15 111.677 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.07 -31.22 68.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.165 -0.471 . . . . 1.33 110.709 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -85.32 2.87 42.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.729 0.775 . . . . 1.24 109.822 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -124.0 89.5 51.62 Favored Pre-proline 0 CA--C 1.508 -0.649 0 CA-C-N 114.983 -1.008 . . . . 0.43 109.333 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 13' ' ' VAL . 50.1 Cg_exo -56.17 -18.88 25.13 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.55 2.167 . . . . 0.67 112.803 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.39 -32.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.587 0.708 . . . . 1.26 110.305 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 34.6 t -75.7 -43.47 47.05 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.334 -0.546 . . . . 1.29 109.709 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.693 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 ptm180 -72.83 -17.48 61.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.472 0.915 . . . . 2.15 113.472 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 9' ' ' PRO . 8.2 m -82.56 -33.22 10.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.705 -0.225 . . . . 1.52 111.404 175.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 1.3 p30 -89.61 -33.55 16.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.475 -0.49 . . . . 1.71 111.476 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.693 ' OD1' ' HA ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -65.08 154.61 37.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.242 0.544 . . . . 2.56 111.684 -177.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -148.36 46.82 1.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.103 -0.499 . . . . 4.56 109.765 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG22 ' CG ' ' A' ' 15' ' ' ASN . 2.9 m -90.42 3.15 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.257 0.551 . . . . 2.52 110.855 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.305 -0.855 . . . . 3.23 109.404 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 35.0 pt . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.043 0.449 . . . . 6.78 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -113.24 68.26 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.053 -0.521 . . . . 7.47 110.204 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.91 79.56 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.763 -0.653 . . . . 3.82 110.058 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.27 -46.31 2.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.8 -0.636 . . . . 2.94 110.856 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' C ' ' HB2' ' A' ' 19' ' ' CYS . 1.7 m -92.46 -7.03 48.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.122 -0.49 . . . . 1.15 111.3 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 19' ' ' CYS . 49.9 m -67.3 -25.19 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.465 -0.334 . . . . 1.33 111.467 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -90.51 14.47 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.831 0.824 . . . . 1.24 109.454 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.563 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 23.7 m-80 -130.25 94.74 29.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.107 -0.951 . . . . 0.43 109.057 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.442 ' O ' HG13 ' A' ' 13' ' ' VAL . 28.7 Cg_endo -60.11 -16.13 37.97 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.362 2.041 . . . . 0.67 112.818 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.74 -39.01 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 1.26 110.366 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 t -71.57 -35.16 70.48 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.51 -0.476 . . . . 1.29 110.367 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 14.4 ptm180 -82.17 -17.82 44.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.018 1.118 . . . . 2.15 114.018 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 9' ' ' PRO . 3.7 m -71.69 -33.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 O-C-N 121.89 -0.506 . . . . 1.52 111.045 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.67 -50.77 63.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.228 -0.589 . . . . 1.71 110.121 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' HA ' HD23 ' A' ' 16' ' ' HYP . 19.6 p30 -81.57 158.41 24.41 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.448 -0.796 . . . . 2.56 111.653 -172.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 72.23 12.59 5.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.559 -0.746 . . . . 4.56 110.468 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.33 69.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.509 -0.923 . . . . 2.52 108.509 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' CYS . 2.1 p . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.036 -0.984 . . . . 3.23 111.585 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.892 -0.41 . . . . 6.78 109.892 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -84.43 115.3 22.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.643 -0.502 . . . . 7.47 109.643 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -82.23 57.93 3.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.194 0.521 . . . . 3.82 110.208 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.87 -55.14 4.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.802 -0.635 . . . . 2.94 110.274 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.529 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.6 p -68.34 -10.37 54.42 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 1.15 110.728 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 34.3 t -63.31 -26.9 68.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.15 -0.477 . . . . 1.33 110.697 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -85.48 7.17 23.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.443 0.639 . . . . 1.24 110.1 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.2 m-80 -115.84 114.93 41.59 Favored Pre-proline 0 CA--C 1.513 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.43 109.78 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 -15.61 47.99 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.078 1.852 . . . . 0.67 112.99 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -83.98 -28.35 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 1.26 110.475 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 46.6 t -82.36 -44.0 16.7 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.702 -0.799 . . . . 1.29 110.428 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.564 ' HA ' HD22 ' A' ' 15' ' ' ASN . 13.7 ptt180 -72.13 -17.76 61.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.949 0.722 . . . . 2.15 112.949 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.43 -40.71 42.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.505 -0.316 . . . . 1.52 110.852 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 8.5 p30 -88.06 -30.61 19.79 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.382 -0.527 . . . . 1.71 111.144 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.601 ' CG ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -67.99 132.71 47.8 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.148 0.975 . . . . 2.56 110.628 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.478 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -154.14 49.38 0.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.037 -0.529 . . . . 4.56 111.678 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.601 HG12 ' CG ' ' A' ' 15' ' ' ASN . 4.3 p -93.02 -30.98 4.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.667 -0.813 . . . . 2.52 108.934 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.1 -0.955 . . . . 3.23 108.694 174.067 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.674 0.75 . . . . 6.78 110.895 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.582 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . 5.1 mmp_? -136.45 41.93 2.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.202 -0.908 . . . . 7.47 108.911 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.651 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 5.1 m-20 -94.14 50.18 1.37 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.132 -0.94 . . . . 3.82 111.346 -169.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.16 -62.43 1.38 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.946 -0.57 . . . . 2.94 110.782 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.9 m -60.15 -25.78 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.446 . . . . 1.15 111.843 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.0 m -62.54 -28.74 70.06 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 1.33 111.116 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t -91.45 -5.34 54.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 1.24 110.22 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 21.6 m-80 -118.98 102.75 48.84 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-N 115.646 -0.706 . . . . 0.43 109.946 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.31 -18.36 37.57 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.169 1.913 . . . . 0.67 113.034 -175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 13' ' ' VAL . 9.8 p -80.6 -37.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.519 0.676 . . . . 1.26 110.666 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 13.2 t -76.46 -42.27 44.36 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.998 -0.681 . . . . 1.29 110.141 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 12.0 ptm180 -73.38 -26.23 60.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.026 0.75 . . . . 2.15 113.026 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 10' ' ' VAL . 8.9 p -66.95 -40.81 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.696 0.284 . . . . 1.52 111.294 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' HG13 ' A' ' 13' ' ' VAL . 8.0 p30 -90.11 -21.9 22.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 1.71 110.888 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -69.64 138.76 53.31 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.696 0.76 . . . . 2.56 111.141 -177.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.457 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.9 m80 60.86 42.9 12.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 4.56 111.442 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.56 -42.55 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.009 -0.738 . . . . 2.52 109.009 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 3' ' ' ASP . 49.8 t . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.657 -1.156 . . . . 3.23 108.184 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.993 -0.373 . . . . 6.78 109.993 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -128.67 30.3 5.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 7.47 110.877 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -93.15 98.7 11.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.816 -0.629 . . . . 3.82 110.211 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.59 11.7 38.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 2.94 111.205 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HA ' HD22 ' A' ' 8' ' ' ASN . 0.8 OUTLIER -68.61 -6.49 26.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.236 -0.438 . . . . 1.15 111.49 -177.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.4 m -60.41 -26.02 66.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.745 0.307 . . . . 1.33 111.099 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -87.03 15.93 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.856 0.836 . . . . 1.24 109.287 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.568 HD22 ' HA ' ' A' ' 5' ' ' CYS . 16.9 m-80 -129.77 97.88 23.21 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 114.728 -1.123 . . . . 0.43 108.121 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -54.3 -25.61 39.6 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.197 1.932 . . . . 0.67 112.679 -174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -73.76 -35.18 42.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.975 0.417 . . . . 1.26 110.396 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.1 t -67.98 -40.23 83.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 1.29 110.428 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 11.9 ptm180 -82.49 -34.14 28.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.498 0.925 . . . . 2.15 113.498 -171.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.7 m -58.82 -48.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 111.749 0.277 . . . . 1.52 111.749 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.419 HD22 ' C ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -91.81 -3.05 56.59 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.716 -0.394 . . . . 1.71 111.961 -176.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -159.39 92.04 1.04 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 2.56 110.529 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -118.15 -32.28 4.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.011 0.374 . . . . 4.56 112.011 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 p -58.98 -32.26 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.921 0.391 . . . . 2.52 111.09 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 24.5 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.87 -0.586 . . . . 3.23 110.039 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.648 0.261 . . . . 6.78 110.766 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -160.18 47.71 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 7.47 109.367 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.51 -3.15 32.46 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.595 -0.729 . . . . 3.82 110.621 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.04 -23.93 60.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.754 -1.112 . . . . 2.94 110.751 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -64.37 -14.75 58.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.468 0.544 . . . . 1.15 112.468 -172.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.55 -37.82 80.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 1.33 110.597 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.8 t -82.71 4.95 22.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.649 0.737 . . . . 1.24 109.8 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.29 107.64 47.01 Favored Pre-proline 0 CA--C 1.509 -0.614 0 CA-C-N 115.12 -0.945 . . . . 0.43 109.482 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.58 -20.5 70.92 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.622 1.548 . . . . 0.67 111.935 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -73.83 -31.29 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.396 0.617 . . . . 1.26 109.639 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 73.9 m -76.19 -56.28 4.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.82 -0.627 . . . . 1.29 110.595 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -63.6 -19.22 64.67 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.907 0.706 . . . . 2.15 112.907 -173.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -89.78 -35.51 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 112.336 0.495 . . . . 1.52 112.336 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 11' ' ' CYS . 2.4 p30 -80.13 -31.13 39.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.131 -0.628 . . . . 1.71 110.063 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -84.41 160.27 20.65 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 109.328 -0.619 . . . . 2.56 109.328 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 58.73 57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.726 . . . . 4.56 110.624 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.51 -32.31 49.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.805 -0.634 . . . . 2.52 110.169 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.707 -0.663 . . . . 3.23 109.464 175.847 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.059 -0.348 . . . . 6.78 110.059 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -71.7 129.77 39.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.67 -0.493 . . . . 7.47 109.67 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.29 40.73 1.26 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.236 0.541 . . . . 3.82 111.789 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.8 -20.34 61.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.629 -0.714 . . . . 2.94 110.847 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -61.55 -8.2 4.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.153 -0.476 . . . . 1.15 112.084 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.1 -33.32 73.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.995 0.426 . . . . 1.33 110.241 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -85.32 1.1 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 1.24 109.719 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -119.52 90.69 43.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.676 -1.147 . . . . 0.43 108.771 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.573 ' O ' HG13 ' A' ' 13' ' ' VAL . 18.5 Cg_endo -56.73 -22.16 43.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.134 1.89 . . . . 0.67 112.495 -174.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.67 -31.85 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.522 0.677 . . . . 1.26 110.077 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HA ' HD21 ' A' ' 14' ' ' ASN . 38.3 t -76.72 -32.79 58.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.099 -0.5 . . . . 1.29 110.286 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -83.12 -21.56 33.59 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.515 0.932 . . . . 2.15 113.515 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 9' ' ' PRO . 16.3 m -72.33 -36.14 54.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 111.76 0.282 . . . . 1.52 111.76 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 11' ' ' CYS . 9.6 p30 -87.27 -10.05 53.4 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.594 -0.442 . . . . 1.71 110.575 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -136.3 79.97 1.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.811 -0.631 . . . . 2.56 109.329 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -147.24 13.36 1.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.044 0.45 . . . . 4.56 110.562 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.734 -0.469 . . . . 2.52 109.734 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.253 1.255 0 CA-C-N 115.605 -0.725 . . . . 3.23 109.152 178.231 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.3 pt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.298 -0.26 . . . . 6.78 110.298 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -80.24 97.53 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.011 0.434 . . . . 7.47 110.064 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.26 0.47 14.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.206 0.527 . . . . 3.82 111.508 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.0 -14.55 60.63 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.495 -0.775 . . . . 2.94 110.065 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 1.5 m -63.45 -7.6 7.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.016 -0.538 . . . . 1.15 112.408 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.3 m -65.09 -37.2 86.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.484 -0.562 . . . . 1.33 109.484 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -87.58 7.23 30.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.635 -0.711 . . . . 1.24 109.98 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 5' ' ' CYS . 17.6 m-80 -120.7 93.24 48.5 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-N 115.186 -0.915 . . . . 0.43 108.925 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.85 -22.78 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.047 1.831 . . . . 0.67 112.511 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 11' ' ' CYS . 14.0 p -64.1 -46.89 92.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 1.26 110.216 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.42 ' N ' HG13 ' A' ' 10' ' ' VAL . 81.0 m -61.72 -55.39 30.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.54 -0.755 . . . . 1.29 111.154 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 10.5 ptm180 -70.38 -16.71 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.158 0.799 . . . . 2.15 113.158 -171.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.09 -40.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.145 0.424 . . . . 1.52 112.145 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.32 -25.11 42.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.915 -0.714 . . . . 1.71 109.755 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -140.68 90.41 2.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.988 -0.745 . . . . 2.56 108.988 -177.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -166.86 28.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.911 -1.04 . . . . 4.56 108.324 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.55 -29.14 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.274 -0.875 . . . . 2.52 110.421 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.249 1.051 0 CA-C-N 116.092 -0.503 . . . . 3.23 110.209 175.388 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 110.426 -0.212 . . . . 6.78 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 64.94 173.77 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.813 0.816 . . . . 7.47 112.367 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.0 t70 -148.92 126.05 11.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.12 -0.945 . . . . 3.82 108.859 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.87 -16.38 63.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.363 -0.38 . . . . 2.94 111.607 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.681 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -66.82 -10.07 43.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.15 110.896 177.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.6 t -63.79 -32.41 73.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.124 -0.489 . . . . 1.33 110.133 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 t -88.77 17.15 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.538 0.685 . . . . 1.24 110.105 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 27.2 m-80 -132.93 104.68 12.71 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-N 115.579 -0.737 . . . . 0.43 109.974 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' O ' HG22 ' A' ' 13' ' ' VAL . 51.1 Cg_exo -56.9 -24.44 56.62 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.895 1.73 . . . . 0.67 112.196 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.44 -33.53 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.828 0.823 . . . . 1.26 110.301 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.8 m -73.83 -43.38 58.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.532 -0.758 . . . . 1.29 109.946 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 28.9 mtp180 -68.71 -38.95 80.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.234 -0.894 . . . . 2.15 112.898 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 9' ' ' PRO . 15.8 m -63.5 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.806 -0.634 . . . . 1.52 112.205 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -87.13 -34.49 19.07 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.654 -0.418 . . . . 1.71 111.281 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HA ' HD23 ' A' ' 16' ' ' HYP . 4.1 m120 -88.0 141.59 28.45 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.945 0.879 . . . . 2.56 110.554 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.422 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -159.76 55.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 4.56 111.399 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.75 -28.04 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.163 0.506 . . . . 2.52 110.318 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.732 . . . . 3.23 109.672 176.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 19' ' ' CYS . 5.2 mp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.703 -0.48 . . . . 6.78 109.703 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -82.59 62.11 6.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.197 0.522 . . . . 7.47 110.73 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -149.04 123.79 9.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.626 -0.715 . . . . 3.82 109.814 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.66 -20.29 33.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.116 -0.493 . . . . 2.94 110.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.29 -17.74 62.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.15 110.808 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 46.6 t -59.72 -36.36 76.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.86 -0.609 . . . . 1.33 111.323 174.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -84.16 -6.82 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.433 0.635 . . . . 1.24 109.797 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 24.8 m-80 -99.63 111.61 61.94 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.43 110.125 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.88 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.716 1.611 . . . . 0.67 112.442 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.91 -42.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.494 0.664 . . . . 1.26 110.035 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -69.44 -52.6 25.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.125 -0.943 . . . . 1.29 111.374 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 8.7 ptm180 -64.94 -21.02 66.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.942 0.719 . . . . 2.15 112.942 -175.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 t -88.65 -38.52 11.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.035 0.445 . . . . 1.52 111.943 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -81.33 -21.2 39.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.431 0.634 . . . . 1.71 110.266 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.494 HD22 ' HB ' ' A' ' 18' ' ' VAL . 6.6 t30 -144.07 85.93 1.83 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.205 -0.665 . . . . 2.56 109.205 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -150.13 30.98 0.69 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.794 0.807 . . . . 4.56 108.911 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.494 ' HB ' HD22 ' A' ' 15' ' ' ASN . 9.4 p -87.57 -26.16 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.372 -0.831 . . . . 2.52 110.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.489 ' O ' HG12 ' A' ' 1' ' ' ILE . 23.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.515 -0.755 . . . . 3.23 109.877 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.3 pt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.033 0.445 . . . . 6.78 111.642 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -115.2 129.39 56.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.695 -0.483 . . . . 7.47 109.695 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.22 -165.74 1.12 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.368 -0.605 . . . . 3.82 109.368 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.73 -36.83 59.83 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.721 0.296 . . . . 2.94 111.204 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HA ' HD22 ' A' ' 8' ' ' ASN . 1.1 p -69.1 -8.41 45.05 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.766 0.284 . . . . 1.15 111.766 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -65.16 -28.59 69.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.733 0.301 . . . . 1.33 111.283 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.5 p -79.93 4.19 17.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.873 0.844 . . . . 1.24 109.729 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 5' ' ' CYS . 26.3 m-80 -116.66 106.23 48.6 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.597 -1.183 . . . . 0.43 109.392 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 13' ' ' VAL . 52.6 Cg_exo -54.62 -24.18 35.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.198 1.932 . . . . 0.67 112.686 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -73.82 -35.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.246 0.546 . . . . 1.26 110.794 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.4 t -72.85 -37.56 67.37 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 1.29 110.326 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.797 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.1 ptm180 -82.2 -18.15 43.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.728 1.01 . . . . 2.15 113.728 -172.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 9' ' ' PRO . 10.8 m -78.22 -34.14 18.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 111.519 0.192 . . . . 1.52 111.519 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.24 -36.09 14.94 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.536 -0.465 . . . . 1.71 111.583 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.797 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -77.66 157.47 30.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.947 0.403 . . . . 2.56 110.183 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 54.96 45.55 26.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.666 . . . . 4.56 111.94 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.78 -15.68 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.799 0.809 . . . . 2.52 108.836 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 12' ' ' ARG . 93.0 m . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.791 -1.095 . . . . 3.23 109.58 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.64 0.257 . . . . 6.78 110.681 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -152.0 77.14 1.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.217 0.532 . . . . 7.47 110.01 174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 5' ' ' CYS . 9.5 t70 -154.83 129.89 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.713 -0.847 . . . . 3.82 108.713 176.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.8 -26.94 60.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.614 -0.721 . . . . 2.94 111.205 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 m -73.62 -8.17 54.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.118 0.414 . . . . 1.15 112.118 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 3' ' ' ASP . 63.5 m -64.97 -37.01 86.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.869 0.366 . . . . 1.33 110.633 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.6 m -89.06 21.04 3.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.844 0.83 . . . . 1.24 109.75 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -127.31 98.48 29.39 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-N 114.891 -1.05 . . . . 0.43 109.13 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.22 -13.74 37.56 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.745 1.63 . . . . 0.67 111.793 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' VAL . 84.1 t -78.81 -32.49 15.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.301 0.572 . . . . 1.26 110.184 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.6 m -72.17 -51.06 23.0 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.898 0.38 . . . . 1.29 110.196 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.703 ' HB3' ' OXT' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.89 -17.67 60.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.621 0.971 . . . . 2.15 113.621 -171.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 10' ' ' VAL . 7.1 p -71.09 -38.61 72.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 121.12 -0.232 . . . . 1.52 110.612 173.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.24 -28.2 14.64 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.293 0.479 . . . . 1.71 112.293 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 12' ' ' ARG . 30.0 p30 -68.64 139.03 55.46 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.301 1.048 . . . . 2.56 111.045 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . 0.409 HD23 ' HA ' ' A' ' 15' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -156.93 39.82 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 4.56 111.357 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -82.63 -73.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.41 . . . . 2.52 110.702 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.703 ' OXT' ' HB3' ' A' ' 12' ' ' ARG . 50.8 t . . . . . 0 C--O 1.252 1.233 0 N-CA-C 108.864 -0.791 . . . . 3.23 108.864 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.788 0.327 . . . . 6.78 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -120.81 37.95 4.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.342 0.592 . . . . 7.47 110.584 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 19.2 m-20 -98.49 30.79 3.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.941 -0.572 . . . . 3.82 110.979 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -67.22 -56.32 10.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 2.94 110.491 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.558 ' HA ' HD22 ' A' ' 8' ' ' ASN . 1.2 m -67.86 -6.92 23.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 1.15 111.75 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 48.6 t -66.58 -18.89 65.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.432 0.634 . . . . 1.33 110.548 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -101.96 6.52 41.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.696 -0.684 . . . . 1.24 109.759 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.558 HD22 ' HA ' ' A' ' 5' ' ' CYS . 20.2 m-80 -117.15 111.1 40.68 Favored Pre-proline 0 CA--C 1.507 -0.698 0 CA-C-N 115.318 -0.856 . . . . 0.43 109.14 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.1 Cg_endo -62.61 -21.54 73.0 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.782 1.655 . . . . 0.67 112.433 -172.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.8 t -80.56 -41.38 20.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.339 -0.391 . . . . 1.26 110.578 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.11 -39.26 81.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.37 0.605 . . . . 1.29 110.665 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 52.3 mtp180 -73.6 -35.18 65.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.957 -1.02 . . . . 2.15 112.112 -172.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 9' ' ' PRO . 20.2 m -84.87 -22.55 7.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.221 -0.899 . . . . 1.52 111.621 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.95 -31.75 20.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.342 0.591 . . . . 1.71 110.119 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -136.8 85.24 2.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.549 -0.751 . . . . 2.56 109.028 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -139.01 56.14 1.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.516 -0.766 . . . . 4.56 109.281 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.73 -33.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 2.52 110.968 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.703 -0.665 . . . . 3.23 109.902 -177.924 . . . . . . . . 0 0 . 1 stop_ save_